sharon sanders
Editor-in-Chief & President
bump this
-
FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
-
We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.
COVID- 19 Vaccine Dangers, Side Effects, Controversy - Closed thread, please see scientific library
- Thread starter GardenSpider
- Start date
- Status
GardenSpider
Well-known member
SHOCKING AND APPALLING: Just look at this very long list of "adverse events of special interest" in Pfizer's very own safety data report!
See attachment for their data sets and tables. Keep in mind that Pfizer has been caught and is being sued for manipulating data sets to hide signals indicating the vaccines could be dangerous to human health.
BNT162b2
5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021
PAGE 30: APPENDIX 1. LIST OF ADVERSE EVENTS OF SPECIAL INTEREST
Report Prepared by: Worldwide Safety Pfizer
BNT162b2
5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports
APPENDIX 1. LIST OF ADVERSE EVENTS OF SPECIAL INTEREST
1p36 deletion syndrome;2-Hydroxyglutaric aciduria;5'nucleotidase increased;Acoustic neuritis;Acquired C1 inhibitor deficiency;Acquired epidermolysis bullosa;Acquired epileptic aphasia;Acute cutaneous lupus erythematosus;Acute disseminated encephalomyelitis;Acute encephalitis with refractory, repetitive partial seizures;Acute febrile neutrophilic dermatosis;Acute flaccid myelitis;Acute haemorrhagic leukoencephalitis;Acute haemorrhagic oedema of infancy;Acute kidney injury;Acute macular outer retinopathy;Acute motor axonal neuropathy;Acute motor-sensory axonal neuropathy;Acute myocardial infarction;Acute respiratory distress syndrome;Acute respiratory failure;Addison's disease;Administration site thrombosis;Administration site vasculitis;Adrenal thrombosis;Adverse event following immunisation;Ageusia;Agranulocytosis;Air embolism;Alanine aminotransferase abnormal;Alanine aminotransferase increased;Alcoholic seizure;Allergic bronchopulmonary mycosis;Allergic oedema;Alloimmune hepatitis;Alopecia areata;Alpers disease;Alveolar proteinosis;Ammonia abnormal;Ammonia increased;Amniotic cavity infection;Amygdalohippocampectomy;Amyloid arthropathy;Amyloidosis;Amyloidosis senile;Anaphylactic reaction;Anaphylactic shock;Anaphylactic transfusion reaction;Anaphylactoid reaction;Anaphylactoid shock;Anaphylactoid syndrome of pregnancy;Angioedema;Angiopathic neuropathy;Ankylosing spondylitis;Anosmia;Antiacetylcholine receptor antibody positive;Anti-actin antibody positive;Anti-aquaporin-4 antibody positive;Anti-basal ganglia antibody positive;Anti-cyclic citrullinated peptide antibody positive;Anti-epithelial antibody positive;Anti-erythrocyte antibody positive;Anti-exosome complex antibody positive;Anti- GAD antibody negative;Anti-GAD antibody positive;Anti-ganglioside antibody positive;Antigliadin antibody positive;Anti-glomerular basement membrane antibody positive;Anti-glomerular basement membrane disease;Anti-glycyl-tRNA synthetase antibody positive;Anti-HLA antibody test positive;Anti-IA2 antibody positive;Anti-insulin antibody increased;Anti-insulin antibody positive;Anti-insulin receptor antibody increased;Anti- insulin receptor antibody positive;Anti-interferon antibody negative;Anti-interferon antibody positive;Anti-islet cell antibody positive;Antimitochondrial antibody positive;Anti-muscle specific kinase antibody positive;Anti-myelin-associated glycoprotein antibodies positive;Anti-myelin-associated glycoprotein associated polyneuropathy;Antimyocardial antibody positive;Anti-neuronal antibody positive;Antineutrophil cytoplasmic antibody increased;Antineutrophil cytoplasmic antibody positive;Anti-neutrophil cytoplasmic antibody positive vasculitis;Anti-NMDA antibody positive;Antinuclear antibody increased;Antinuclear antibody positive;Antiphospholipid antibodies positive;Antiphospholipid syndrome;Anti-platelet antibody positive;Anti-prothrombin antibody positive;Antiribosomal P antibody positive;Anti-RNA polymerase III antibody positive;Anti-saccharomyces cerevisiae antibody test positive;Anti-sperm antibody positive;Anti-SRP antibody positive;Antisynthetase syndrome;Anti-thyroid antibody positive;Anti-transglutaminase antibody increased;Anti-VGCC antibody positive;Anti- VGKC antibody positive;Anti-vimentin antibody positive;Antiviral prophylaxis;Antiviral treatment;Anti-zinc transporter 8 antibody positive;Aortic embolus;Aortic thrombosis;Aortitis;Aplasia pure red cell;Aplastic anaemia;Application site thrombosis;Application site vasculitis;Arrhythmia;Arterial bypass occlusion;Arterial bypass thrombosis;Arterial thrombosis;Arteriovenous fistula thrombosis;Arteriovenous graft site stenosis;Arteriovenous graft thrombosis;Arteritis;Arteritis: coronary;Arthralgia;Arthritis;Arthritis enteropathic;Ascites;Aseptic cavernous sinus thrombosis;Aspartate aminotransferase abnormal;Aspartate aminotransferase increased;Aspartate-glutamate-transporter deficiency;AST to platelet ratio index increased;AST/ALT ratio abnormal;Asthma;Asymptomatic COVID- 19;Ataxia;Atheroembolism;Atonic seizures;Atrial thrombosis;Atrophic thyroiditis;Atypical benign partial epilepsy;Atypical pneumonia;Aura;Autoantibody positive;Autoimmune anaemia;Autoimmune aplastic anaemia;Autoimmune arthritis;Autoimmune blistering disease;Autoimmune cholangitis;Autoimmune colitis;Autoimmune demyelinating disease;Autoimmune dermatitis;Autoimmune disorder;Autoimmune encephalopathy;Autoimmune endocrine disorder;Autoimmune enteropathy;Autoimmune eye disorder;Autoimmune haemolytic anaemia;Autoimmune heparin-induced thrombocytopenia;Autoimmune hepatitis;Autoimmune hyperlipidaemia;Autoimmune hypothyroidism;Autoimmune inner ear disease;Autoimmune lung disease;Autoimmune lymphoproliferative syndrome;Autoimmune myocarditis;Autoimmune myositis;Autoimmune nephritis;Autoimmune neuropathy;Autoimmune neutropenia;Autoimmune pancreatitis;Autoimmune pancytopenia;Autoimmune pericarditis;Autoimmune retinopathy;Autoimmune thyroid disorder;Autoimmune thyroiditis;Autoimmune uveitis;Autoinflammation with infantile enterocolitis;Autoinflammatory disease;Automatism epileptic;Autonomic nervous system imbalance;Autonomic seizure;Axial spondyloarthritis;Axillary vein thrombosis;Axonal and demyelinating polyneuropathy;Axonal neuropathy;Bacterascites;Baltic myoclonic epilepsy;Band sensation;Basedow's disease;Basilar artery thrombosis;Basophilopenia;B-cell aplasia;Behcet's syndrome;Benign ethnic neutropenia;Benign familial neonatal convulsions;Benign familial pemphigus;Benign rolandic epilepsy;Beta-2 glycoprotein antibody positive;Bickerstaff's encephalitis;Bile output abnormal;Bile output decreased;Biliary ascites;Bilirubin conjugated abnormal;Bilirubin conjugated increased;Bilirubin urine present;Biopsy liver abnormal;Biotinidase deficiency;Birdshot chorioretinopathy;Blood alkaline phosphatase abnormal;Blood alkaline phosphatase increased;Blood bilirubin abnormal;Blood bilirubin increased;Blood bilirubin unconjugated increased;Blood cholinesterase abnormal;Blood cholinesterase decreased;Blood pressure decreased;Blood pressure diastolic decreased;Blood pressure systolic decreased;Blue toe syndrome;Brachiocephalic vein thrombosis;Brain stem embolism;Brain stem thrombosis;Bromosulphthalein test abnormal;Bronchial oedema;Bronchitis;Bronchitis mycoplasmal;Bronchitis viral;Bronchopulmonary aspergillosis allergic;Bronchospasm;Budd- Chiari syndrome;Bulbar palsy;Butterfly rash;C1q nephropathy;Caesarean section;Calcium embolism;Capillaritis;Caplan's syndrome;Cardiac amyloidosis;Cardiac arrest;Cardiac failure;Cardiac failure acute;Cardiac sarcoidosis;Cardiac ventricular thrombosis;Cardiogenic shock;Cardiolipin antibody positive;Cardiopulmonary failure;Cardio-respiratory arrest;Cardio-respiratory distress;Cardiovascular insufficiency;Carotid arterial embolus;Carotid artery thrombosis;Cataplexy;Catheter site thrombosis;Catheter site vasculitis;Cavernous sinus thrombosis;CDKL5 deficiency disorder;CEC syndrome;Cement embolism;Central nervous system lupus;Central nervous system vasculitis;Cerebellar artery thrombosis;Cerebellar embolism;Cerebral amyloid angiopathy;Cerebral arteritis;Cerebral artery embolism;Cerebral artery thrombosis;Cerebral gas embolism;Cerebral microembolism;Cerebral septic infarct;Cerebral thrombosis;Cerebral venous sinus thrombosis;Cerebral venous thrombosis;Cerebrospinal thrombotic tamponade;Cerebrovascular accident;Change in seizure presentation;Chest discomfort;Child- Pugh-Turcotte score abnormal;Child-Pugh-Turcotte score increased;Chillblains;Choking;Choking sensation;Cholangitis sclerosing;Chronic autoimmune glomerulonephritis;Chronic cutaneous lupus erythematosus;Chronic fatigue syndrome;Chronic gastritis;Chronic inflammatory demyelinating polyradiculoneuropathy;Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids;Chronic recurrent multifocal osteomyelitis;Chronic respiratory failure;Chronic spontaneous urticaria;Circulatory collapse;Circumoral oedema;Circumoral swelling;Clinically isolated syndrome;Clonic convulsion;Coeliac disease;Cogan's syndrome;Cold agglutinins positive;Cold type haemolytic anaemia;Colitis;Colitis erosive;Colitis herpes;Colitis microscopic;Colitis ulcerative;Collagen disorder;Collagen-vascular disease;Complement factor abnormal;Complement factor C1 decreased;Complement factor C2 decreased;Complement factor C3 decreased;Complement factor C4 decreased;Complement factor decreased;Computerised tomogram liver abnormal;Concentric sclerosis;Congenital anomaly;Congenital bilateral perisylvian syndrome;Congenital herpes simplex infection;Congenital myasthenic syndrome;Congenital varicella infection;Congestive hepatopathy;Convulsion in childhood;Convulsions local;Convulsive threshold lowered;Coombs positive haemolytic anaemia;Coronary artery disease;Coronary artery embolism;Coronary artery thrombosis;Coronary bypass thrombosis;Coronavirus infection;Coronavirus test;Coronavirus test negative;Coronavirus test positive;Corpus callosotomy;Cough;Cough variant asthma;COVID-19;COVID-19 immunisation;COVID-19 pneumonia;COVID-19 prophylaxis;COVID-19 treatment;Cranial nerve disorder;Cranial nerve palsies multiple;Cranial nerve paralysis;CREST syndrome;Crohn's disease;Cryofibrinogenaemia;Cryoglobulinaemia;CSF oligoclonal band present;CSWS syndrome;Cutaneous amyloidosis;Cutaneous lupus erythematosus;Cutaneous sarcoidosis;Cutaneous vasculitis;Cyanosis;Cyclic neutropenia;Cystitis interstitial;Cytokine release syndrome;Cytokine storm;De novo purine synthesis inhibitors associated acute inflammatory syndrome;Death neonatal;Deep vein thrombosis;Deep vein thrombosis postoperative;Deficiency of bile secretion;Deja vu;Demyelinating polyneuropathy;Demyelination;Dermatitis;Dermatitis bullous;Dermatitis herpetiformis;Dermatomyositis;Device embolisation;Device related thrombosis;Diabetes mellitus;Diabetic ketoacidosis;Diabetic mastopathy;Dialysis amyloidosis;Dialysis membrane reaction;Diastolic hypotension;Diffuse vasculitis;Digital pitting scar;Disseminated intravascular coagulation;Disseminated intravascular coagulation in newborn;Disseminated neonatal herpes simplex;Disseminated varicella;Disseminated varicella zoster vaccine virus infection;Disseminated varicella zoster virus infection;DNA antibody positive;Double cortex syndrome;Double stranded DNA antibody positive;Dreamy state;Dressler's syndrome;Drop attacks;Drug withdrawal convulsions;Dyspnoea;Early infantile epileptic encephalopathy with burst-suppression;Eclampsia;Eczema herpeticum;Embolia cutis medicamentosa;Embolic cerebellar infarction;Embolic cerebral infarction;Embolic pneumonia;Embolic stroke;Embolism;Embolism arterial;Embolism venous;Encephalitis;Encephalitis allergic;Encephalitis autoimmune;Encephalitis brain stem;Encephalitis haemorrhagic;Encephalitis periaxialis diffusa;Encephalitis post immunisation;Encephalomyelitis;Encephalopathy;Endo crine disorder;Endocrine ophthalmopathy;Endotracheal intubation;Enteritis;Enteritis leukopenic;Enterobacter pneumonia;Enterocolitis;Enteropathic spondylitis;Eosinopenia;Eosinophilic fasciitis;Eosinophilic granulomatosis with polyangiitis;Eosinophilic oesophagitis;Epidermolysis;Epilepsy;Epilepsy surgery;Epilepsy with myoclonic-atonic seizures;Epileptic aura;Epileptic psychosis;Erythema;Erythema induratum;Erythema multiforme;Erythema nodosum;Evans syndrome;Exanthema subitum;Expanded disability status scale score decreased;Expanded disability status scale score increased;Exposure to communicable disease;Exposure to SARS-CoV-2;Eye oedema;Eye pruritus;Eye swelling;Eyelid oedema;Face oedema;Facial paralysis;Facial paresis;Faciobrachial dystonic seizure;Fat embolism;Febrile convulsion;Febrile infection-related epilepsy syndrome;Febrile neutropenia;Felty's syndrome;Femoral artery embolism;Fibrillary glomerulonephritis;Fibromyalgia;Flushing;Foaming at mouth;Focal cortical resection;Focal dyscognitive seizures;Foetal distress syndrome;Foetal placental thrombosis;Foetor hepaticus;Foreign body embolism;Frontal lobe epilepsy;Fulminant type 1 diabetes mellitus;Galactose elimination capacity test abnormal;Galactose elimination capacity test decreased;Gamma-glutamyltransferase abnormal;Gamma-glutamyltransferase increased;Gastritis herpes;Gastrointestinal amyloidosis;Gelastic seizure;Generalised onset non-motor seizure;Generalised tonic-clonic seizure;Genital herpes;Genital herpes simplex;Genital herpes zoster;Giant cell arteritis;Glomerulonephritis;Glomerulonephritis membranoproliferative;Glomerulonephritis membranous;Glomerulonephritis rapidly progressive;Glossopharyngeal nerve paralysis;Glucose transporter type 1 deficiency syndrome;Glutamate dehydrogenase increased;Glycocholic acid increased;GM2 gangliosidosis;Goodpasture's syndrome;Graft thrombosis;Granulocytopenia;Granulocytopenia neonatal;Granulomatosis with polyangiitis;Granulomatous dermatitis;Grey matter heterotopia;Guanase increased;Guillain- Barre syndrome;Haemolytic anaemia;Haemophagocytic lymphohistiocytosis;Haemorrhage;Haemorrhagic ascites;Haemorrhagic disorder;Haemorrhagic pneumonia;Haemorrhagic varicella syndrome;Haemorrhagic vasculitis;Hantavirus pulmonary infection;Hashimoto's encephalopathy;Hashitoxicosis;Hemimegalencephaly;H enoch-Schonlein purpura;Henoch- Schonlein purpura nephritis;Hepaplastin abnormal;Hepaplastin decreased;Heparin-induced thrombocytopenia;Hepatic amyloidosis;Hepatic artery embolism;Hepatic artery flow decreased;Hepatic artery thrombosis;Hepatic enzyme abnormal;Hepatic enzyme decreased;Hepatic enzyme increased;Hepatic fibrosis marker abnormal;Hepatic fibrosis marker increased;Hepatic function abnormal;Hepatic hydrothorax;Hepatic hypertrophy;Hepatic hypoperfusion;Hepatic lymphocytic infiltration;Hepatic mass;Hepatic pain;Hepatic sequestration;Hepatic vascular resistance increased;Hepatic vascular thrombosis;Hepatic vein embolism;Hepatic vein thrombosis;Hepatic venous pressure gradient abnormal;Hepatic venous pressure gradient increased;Hepatitis;Hepatobiliary scan abnormal;Hepatomegaly;Hepatosplenomegaly;Hereditar y angioedema with C1 esterase inhibitor deficiency;Herpes dermatitis;Herpes gestationis;Herpes oesophagitis;Herpes ophthalmic;Herpes pharyngitis;Herpes sepsis;Herpes simplex;Herpes simplex cervicitis;Herpes simplex colitis;Herpes simplex encephalitis;Herpes simplex gastritis;Herpes simplex hepatitis;Herpes simplex meningitis;Herpes simplex meningoencephalitis;Herpes simplex meningomyelitis;Herpes simplex necrotising retinopathy;Herpes simplex oesophagitis;Herpes simplex otitis externa;Herpes simplex pharyngitis;Herpes simplex pneumonia;Herpes simplex reactivation;Herpes simplex sepsis;Herpes simplex viraemia;Herpes simplex virus conjunctivitis neonatal;Herpes simplex visceral;Herpes virus infection;Herpes zoster;Herpes zoster cutaneous disseminated;Herpes zoster infection neurological;Herpes zoster meningitis;Herpes zoster meningoencephalitis;Herpes zoster meningomyelitis;Herpes zoster meningoradiculitis;Herpes zoster necrotising retinopathy;Herpes zoster oticus;Herpes zoster pharyngitis;Herpes zoster reactivation;Herpetic radiculopathy;Histone antibody positive;Hoigne's syndrome;Human herpesvirus 6 encephalitis;Human herpesvirus 6 infection;Human herpesvirus 6 infection reactivation;Human herpesvirus 7 infection;Human herpesvirus 8 infection;Hyperammonaemia;Hyperbilirubinaemia;Hype rcholia;Hypergammaglobulinaemia benign monoclonal;Hyperglycaemic seizure;Hypersensitivity;Hypersensitivity vasculitis;Hyperthyroidism;Hypertransaminasaemia;H yperventilation;Hypoalbuminaemia;H ypocalcaemic seizure;Hypogammaglobulinaemia;Hypoglossal nerve paralysis;Hypoglossal nerve paresis;Hypoglycaemic seizure;Hyponatraemic seizure;Hypotension;Hypotensive crisis;Hypothenar hammer syndrome;Hypothyroidism;Hypoxia;Idiopathic CD4 lymphocytopenia;Idiopathic generalised epilepsy;Idiopathic interstitial pneumonia;Idiopathic neutropenia;Idiopathic pulmonary fibrosis;IgA nephropathy;IgM nephropathy;IIIrd nerve paralysis;IIIrd nerve paresis;Iliac artery embolism;Immune thrombocytopenia;Immune- mediated adverse reaction;Immune-mediated cholangitis;Immune-mediated cholestasis;Immune-mediated cytopenia;Immune-mediated encephalitis;Immune-mediated encephalopathy;Immune-mediated endocrinopathy;Immune-mediated enterocolitis;Immune- mediated gastritis;Immune-mediated hepatic disorder;Immune-mediated hepatitis;Immune- mediated hyperthyroidism;Immune-mediated hypothyroidism;Immune-mediated myocarditis;Immune-mediated myositis;Immune-mediated nephritis;Immune-mediated neuropathy;Immune-mediated pancreatitis;Immune-mediated pneumonitis;Immune-mediated renal disorder;Immune-mediated thyroiditis;Immune-mediated uveitis;Immunoglobulin G4 related disease;Immunoglobulins abnormal;Implant site thrombosis;Inclusion body myositis;Infantile genetic agranulocytosis;Infantile spasms;Infected vasculitis;Infective thrombosis;Inflammation;Inflammatory bowel disease;Infusion site thrombosis;Infusion site vasculitis;Injection site thrombosis;Injection site urticaria;Injection site vasculitis;Instillation site thrombosis;Insulin autoimmune syndrome;Interstitial granulomatous dermatitis;Interstitial lung disease;Intracardiac mass;Intracardiac thrombus;Intracranial pressure increased;Intrapericardial thrombosis;Intrinsic factor antibody abnormal;Intrinsic factor antibody positive;IPEX syndrome;Irregular breathing;IRVAN syndrome;IVth nerve paralysis;IVth nerve paresis;JC polyomavirus test positive;JC virus CSF test positive;Jeavons syndrome;Jugular vein embolism;Jugular vein thrombosis;Juvenile idiopathic arthritis;Juvenile myoclonic epilepsy;Juvenile polymyositis;Juvenile psoriatic arthritis;Juvenile spondyloarthritis;Kaposi sarcoma inflammatory cytokine syndrome;Kawasaki's disease;Kayser-Fleischer ring;Keratoderma blenorrhagica;Ketosis- prone diabetes mellitus;Kounis syndrome;Lafora's myoclonic epilepsy;Lambl's excrescences;Laryngeal dyspnoea;Laryngeal oedema;Laryngeal rheumatoid arthritis;Laryngospasm;Laryngotracheal oedema;Latent autoimmune diabetes in adults;LE cells present;Lemierre syndrome;Lennox-Gastaut syndrome;Leucine aminopeptidase increased;Leukoencephalomyelitis;Leukoencephalopat hy;Leukopenia;Leukopenia neonatal;Lewis-Sumner syndrome;Lhermitte's sign;Lichen planopilaris;Lichen planus;Lichen sclerosus;Limbic encephalitis;Linear IgA disease;Lip oedema;Lip swelling;Liver function test abnormal;Liver function test decreased;Liver function test increased;Liver induration;Liver injury;Liver iron concentration abnormal;Liver iron concentration increased;Liver opacity;Liver palpable;Liver sarcoidosis;Liver scan abnormal;Liver tenderness;Low birth weight baby;Lower respiratory tract herpes infection;Lower respiratory tract infection;Lower respiratory tract infection viral;Lung abscess;Lupoid hepatic cirrhosis;Lupus cystitis;Lupus encephalitis;Lupus endocarditis;Lupus enteritis;Lupus hepatitis;Lupus myocarditis;Lupus myositis;Lupus nephritis;Lupus pancreatitis;Lupus pleurisy;Lupus pneumonitis;Lupus vasculitis;Lupus-like syndrome;Lymphocytic hypophysitis;Lymphocytopenia neonatal;Lymphopenia;MAGIC syndrome;Magnetic resonance imaging liver abnormal;Magnetic resonance proton density fat fraction measurement;Mahler sign;Manufacturing laboratory analytical testing issue;Manufacturing materials issue;Manufacturing production issue;Marburg's variant multiple sclerosis;Marchiafava-Bignami disease;Marine Lenhart syndrome;Mastocytic enterocolitis;Maternal exposure during pregnancy;Medical device site thrombosis;Medical device site vasculitis;MELAS syndrome;Meningitis;Meningitis aseptic;Meningitis herpes;Meningoencephalitis herpes simplex neonatal;Meningoencephalitis herpetic;Meningomyelitis herpes;MERS-CoV test;MERS-CoV test negative;MERS-CoV test positive;Mesangioproliferative glomerulonephritis;Mesenteric artery embolism;Mesenteric artery thrombosis;Mesenteric vein thrombosis;Metapneumovirus infection;Metastatic cutaneous Crohn's disease;Metastatic pulmonary embolism;Microangiopathy;Microembolism;Microscopic polyangiitis;Middle East respiratory syndrome;Migraine-triggered seizure;Miliary pneumonia;Miller Fisher syndrome;Mitochondrial aspartate aminotransferase increased;Mixed connective tissue disease;Model for end stage liver disease score abnormal;Model for end stage liver disease score increased;Molar ratio of total branched-chain amino acid to tyrosine;Molybdenum cofactor deficiency;Monocytopenia;Mononeuritis;Mononeuropat hy multiplex;Morphoea;Morvan syndrome;Mouth swelling;Moyamoya disease;Multifocal motor neuropathy;Multiple organ dysfunction syndrome;Multiple sclerosis;Multiple sclerosis relapse;Multiple sclerosis relapse prophylaxis;Multiple subpial transection;Multisystem inflammatory syndrome in children;Muscular sarcoidosis;Myasthenia gravis;Myasthenia gravis crisis;Myasthenia gravis neonatal;Myasthenic syndrome;Myelitis;Myelitis transverse;Myocardial infarction;Myocarditis;Myocarditis post infection;Myoclonic epilepsy;Myoclonic epilepsy and ragged-red fibres;Myokymia;Myositis;Narcolepsy;Nasal herpes;Nasal obstruction;Necrotising herpetic retinopathy;Neonatal Crohn's disease;Neonatal epileptic seizure;Neonatal lupus erythematosus;Neonatal mucocutaneous herpes simplex;Neonatal pneumonia;Neonatal seizure;Nephritis;Nephrogenic systemic fibrosis;Neuralgic amyotrophy;Neuritis;Neuritis cranial;Neuromyelitis optica pseudo relapse;Neuromyelitis optica spectrum disorder;Neuromyotonia;Neuronal neuropathy;Neuropathy peripheral;Neuropathy, ataxia, retinitis pigmentosa syndrome;Neuropsychiatric lupus;Neurosarcoidosis;Neutropenia;Neutropenia neonatal;Neutropenic colitis;Neutropenic infection;Neutropenic sepsis;Nodular rash;Nodular vasculitis;Noninfectious myelitis;Noninfective encephalitis;Noninfective encephalomyelitis;Noninfective oophoritis;Obstetrical pulmonary embolism;Occupational exposure to communicable disease;Occupational exposure to SARS-CoV-2;Ocular hyperaemia;Ocular myasthenia;Ocular pemphigoid;Ocular sarcoidosis;Ocular vasculitis;Oculofacial paralysis;Oedema;Oedema blister;Oedema due to hepatic disease;Oedema mouth;Oesophageal achalasia;Ophthalmic artery thrombosis;Ophthalmic herpes simplex;Ophthalmic herpes zoster;Ophthalmic vein thrombosis;Optic neuritis;Optic neuropathy;Optic perineuritis;Oral herpes;Oral lichen planus;Oropharyngeal oedema;Oropharyngeal spasm;Oropharyngeal swelling;Osmotic demyelination syndrome;Ovarian vein thrombosis;Overlap syndrome;Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection;Paget-Schroetter syndrome;Palindromic rheumatism;Palisaded neutrophilic granulomatous dermatitis;Palmoplantar keratoderma;Palpable purpura;Pancreatitis;Panencephalitis;Papillophlebi tis;Paracancerous pneumonia;Paradoxical embolism;Parainfluenzae viral laryngotracheobronchitis;Paraneoplastic dermatomyositis;Paraneoplastic pemphigus;Paraneoplastic thrombosis;Paresis cranial nerve;Parietal cell antibody positive;Paroxysmal nocturnal haemoglobinuria;Partial seizures;Partial seizures with secondary generalisation;Patient isolation;Pelvic venous thrombosis;Pemphigoid;Pemphigus;Penile vein thrombosis;Pericarditis;Pericarditis lupus;Perihepatic discomfort;Periorbital oedema;Periorbital swelling;Peripheral artery thrombosis;Peripheral embolism;Peripheral ischaemia;Peripheral vein thrombus extension;Periportal oedema;Peritoneal fluid protein abnormal;Peritoneal fluid protein decreased;Peritoneal fluid protein increased;Peritonitis lupus;Pernicious anaemia;Petit mal epilepsy;Pharyngeal oedema;Pharyngeal swelling;Pityriasis lichenoides et varioliformis acuta;Placenta praevia;Pleuroparenchymal fibroelastosis;Pneumobilia;Pneumonia;Pneumonia adenoviral;Pneumonia cytomegaloviral;Pneumonia herpes viral;Pneumonia influenzal;Pneumonia measles;Pneumonia mycoplasmal;Pneumonia necrotising;Pneumonia parainfluenzae viral;Pneumonia respiratory syncytial viral;Pneumonia viral;POEMS syndrome;Polyarteritis nodosa;Polyarthritis;Polychondritis;Polyglandular autoimmune syndrome type I;Polyglandular autoimmune syndrome type II;Polyglandular autoimmune syndrome type III;Polyglandular disorder;Polymicrogyria;Polymyalgia rheumatica;Polymyositis;Polyneuropathy;Polyneuropa thy idiopathic progressive;Portal pyaemia;Portal vein embolism;Portal vein flow decreased;Portal vein pressure increased;Portal vein thrombosis;Portosplenomesenteric venous thrombosis;Post procedural hypotension;Post procedural pneumonia;Post procedural pulmonary embolism;Post stroke epilepsy;Post stroke seizure;Post thrombotic retinopathy;Post thrombotic syndrome;Post viral fatigue syndrome;Postictal headache;Postictal paralysis;Postictal psychosis;Postictal state;Postoperative respiratory distress;Postoperative respiratory failure;Postoperative thrombosis;Postpartum thrombosis;Postpartum venous thrombosis;Postpericardiotomy syndrome;Post-traumatic epilepsy;Postural orthostatic tachycardia syndrome;Precerebral artery thrombosis;Pre-eclampsia;Preictal state;Premature labour;Premature menopause;Primary amyloidosis;Primary biliary cholangitis;Primary progressive multiple sclerosis;Procedural shock;Proctitis herpes;Proctitis ulcerative;Product availability issue;Product distribution issue;Product supply issue;Progressive facial hemiatrophy;Progressive multifocal leukoencephalopathy;Progressive multiple sclerosis;Progressive relapsing multiple sclerosis;Prosthetic cardiac valve thrombosis;Pruritus;Pruritus allergic;Pseudovasculitis;Psoriasis;Psoriatic arthropathy;Pulmonary amyloidosis;Pulmonary artery thrombosis;Pulmonary embolism;Pulmonary fibrosis;Pulmonary haemorrhage;Pulmonary microemboli;Pulmonary oil microembolism;Pulmonary renal syndrome;Pulmonary sarcoidosis;Pulmonary sepsis;Pulmonary thrombosis;Pulmonary tumour thrombotic microangiopathy;Pulmonary vasculitis;Pulmonary veno-occlusive disease;Pulmonary venous thrombosis;Pyoderma gangrenosum;Pyostomatitis vegetans;Pyrexia;Quarantine;Radiation leukopenia;Radiculitis brachial;Radiologically isolated syndrome;Rash;Rash erythematous;Rash pruritic;Rasmussen encephalitis;Raynaud's phenomenon;Reactive capillary endothelial proliferation;Relapsing multiple sclerosis;Relapsing-remitting multiple sclerosis;Renal amyloidosis;Renal arteritis;Renal artery thrombosis;Renal embolism;Renal failure;Renal vascular thrombosis;Renal vasculitis;Renal vein embolism;Renal vein thrombosis;Respiratory arrest;Respiratory disorder;Respiratory distress;Respiratory failure;Respiratory paralysis;Respiratory syncytial virus bronchiolitis;Respiratory syncytial virus bronchitis;Retinal artery embolism;Retinal artery occlusion;Retinal artery thrombosis;Retinal vascular thrombosis;Retinal vasculitis;Retinal vein occlusion;Retinal vein thrombosis;Retinol binding protein decreased;Retinopathy;Retrograde portal vein flow;Retroperitoneal fibrosis;Reversible airways obstruction;Reynold's syndrome;Rheumatic brain disease;Rheumatic disorder;Rheumatoid arthritis;Rheumatoid factor increased;Rheumatoid factor positive;Rheumatoid factor quantitative increased;Rheumatoid lung;Rheumatoid neutrophilic dermatosis;Rheumatoid nodule;Rheumatoid nodule removal;Rheumatoid scleritis;Rheumatoid vasculitis;Saccadic eye movement;SAPHO syndrome;Sarcoidosis;SARS-CoV-1 test;SARS-CoV-1 test negative;SARS-CoV-1 test positive;SARS-CoV-2 antibody test;SARS-CoV-2 antibody test negative;SARS-CoV-2 antibody test positive;SARS-CoV-2 carrier;SARS-CoV-2 sepsis;SARS-CoV-2 test;SARS- CoV-2 test false negative;SARS-CoV-2 test false positive;SARS-CoV-2 test negative;SARS- CoV-2 test positive;SARS-CoV-2 viraemia;Satoyoshi syndrome;Schizencephaly;Scleritis;Sclerodactylia;S cleroderma;Scleroderma associated digital ulcer;Scleroderma renal crisis;Scleroderma-like reaction;Secondary amyloidosis;Secondary cerebellar degeneration;Secondary progressive multiple sclerosis;Segmented hyalinising vasculitis;Seizure;Seizure anoxic;Seizure cluster;Seizure like phenomena;Seizure prophylaxis;Sensation of foreign body;Septic embolus;Septic pulmonary embolism;Severe acute respiratory syndrome;Severe myoclonic epilepsy of infancy;Shock;Shock symptom;Shrinking lung syndrome;Shunt thrombosis;Silent thyroiditis;Simple partial seizures;Sjogren's syndrome;Skin swelling;SLE arthritis;Smooth muscle antibody positive;Sneezing;Spinal artery embolism;Spinal artery thrombosis;Splenic artery thrombosis;Splenic embolism;Splenic thrombosis;Splenic vein thrombosis;Spondylitis;Spondyloarthropathy;Spontan eous heparin-induced thrombocytopenia syndrome;Status epilepticus;Stevens-Johnson syndrome;Stiff leg syndrome;Stiff person syndrome;Stillbirth;Still's disease;Stoma site thrombosis;Stoma site vasculitis;Stress cardiomyopathy;Stridor;Subacute cutaneous lupus erythematosus;Subacute endocarditis;Subacute inflammatory demyelinating polyneuropathy;Subclavian artery embolism;Subclavian artery thrombosis;Subclavian vein thrombosis;Sudden unexplained death in epilepsy;Superior sagittal sinus thrombosis;Susac's syndrome;Suspected COVID- 19;Swelling;Swelling face;Swelling of eyelid;Swollen tongue;Sympathetic ophthalmia;Systemic lupus erythematosus;Systemic lupus erythematosus disease activity index abnormal;Systemic lupus erythematosus disease activity index decreased;Systemic lupus erythematosus disease activity index increased;Systemic lupus erythematosus rash;Systemic scleroderma;Systemic sclerosis pulmonary;Tachycardia;Tachypnoea;Takayasu's arteritis;Temporal lobe epilepsy;Terminal ileitis;Testicular autoimmunity;Throat tightness;Thromboangiitis obliterans;Thrombocytopenia;Thrombocytopenic purpura;Thrombophlebitis;Thrombophlebitis migrans;Thrombophlebitis
neonatal;Thrombophlebitis septic;Thrombophlebitis superficial;Thromboplastin antibody positive;Thrombosis;Thrombosis corpora cavernosa;Thrombosis in device;Thrombosis mesenteric vessel;Thrombotic cerebral infarction;Thrombotic microangiopathy;Thrombotic stroke;Thrombotic thrombocytopenic purpura;Thyroid disorder;Thyroid stimulating immunoglobulin increased;Thyroiditis;Tongue amyloidosis;Tongue biting;Tongue oedema;Tonic clonic movements;Tonic convulsion;Tonic posturing;Topectomy;Total bile acids increased;Toxic epidermal necrolysis;Toxic leukoencephalopathy;Toxic oil syndrome;Tracheal obstruction;Tracheal oedema;Tracheobronchitis;Tracheobronchitis mycoplasmal;Tracheobronchitis viral;Transaminases abnormal;Transaminases increased;Transfusion-related alloimmune neutropenia;Transient epileptic amnesia;Transverse sinus thrombosis;Trigeminal nerve paresis;Trigeminal neuralgia;Trigeminal palsy;Truncus coeliacus thrombosis;Tuberous sclerosis complex;Tubulointerstitial nephritis and uveitis syndrome;Tumefactive multiple sclerosis;Tumour embolism;Tumour thrombosis;Type 1 diabetes mellitus;Type I hypersensitivity;Type III immune complex mediated reaction;Uhthoff's phenomenon;Ulcerative keratitis;Ultrasound liver abnormal;Umbilical cord thrombosis;Uncinate fits;Undifferentiated connective tissue disease;Upper airway obstruction;Urine bilirubin increased;Urobilinogen urine decreased;Urobilinogen urine increased;Urticaria;Urticaria papular;Urticarial vasculitis;Uterine rupture;Uveitis;Vaccination site thrombosis;Vaccination site vasculitis;Vagus nerve paralysis;Varicella;Varicella keratitis;Varicella post vaccine;Varicella zoster gastritis;Varicella zoster oesophagitis;Varicella zoster pneumonia;Varicella zoster sepsis;Varicella zoster virus infection;Vasa praevia;Vascular graft thrombosis;Vascular pseudoaneurysm thrombosis;Vascular purpura;Vascular stent thrombosis;Vasculitic rash;Vasculitic ulcer;Vasculitis;Vasculitis gastrointestinal;Vasculitis necrotising;Vena cava embolism;Vena cava thrombosis;Venous intravasation;Venous recanalisation;Venous thrombosis;Venous thrombosis in pregnancy;Venous thrombosis limb;Venous thrombosis neonatal;Vertebral artery thrombosis;Vessel puncture site thrombosis;Visceral venous thrombosis;VIth nerve paralysis;VIth nerve paresis;Vitiligo;Vocal cord paralysis;Vocal cord paresis;Vogt-Koyanagi-Harada disease;Warm type haemolytic anaemia;Wheezing;White nipple sign;XIth nerve paralysis;X-ray hepatobiliary abnormal;Young's syndrome;Zika virus associated Guillain Barre syndrome.
CONFIDENTIAL Page 9
FDA-CBER-2021-5683-0000091
See attachment for their data sets and tables. Keep in mind that Pfizer has been caught and is being sued for manipulating data sets to hide signals indicating the vaccines could be dangerous to human health.
BNT162b2
5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021
PAGE 30: APPENDIX 1. LIST OF ADVERSE EVENTS OF SPECIAL INTEREST
Report Prepared by: Worldwide Safety Pfizer
BNT162b2
5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports
APPENDIX 1. LIST OF ADVERSE EVENTS OF SPECIAL INTEREST
1p36 deletion syndrome;2-Hydroxyglutaric aciduria;5'nucleotidase increased;Acoustic neuritis;Acquired C1 inhibitor deficiency;Acquired epidermolysis bullosa;Acquired epileptic aphasia;Acute cutaneous lupus erythematosus;Acute disseminated encephalomyelitis;Acute encephalitis with refractory, repetitive partial seizures;Acute febrile neutrophilic dermatosis;Acute flaccid myelitis;Acute haemorrhagic leukoencephalitis;Acute haemorrhagic oedema of infancy;Acute kidney injury;Acute macular outer retinopathy;Acute motor axonal neuropathy;Acute motor-sensory axonal neuropathy;Acute myocardial infarction;Acute respiratory distress syndrome;Acute respiratory failure;Addison's disease;Administration site thrombosis;Administration site vasculitis;Adrenal thrombosis;Adverse event following immunisation;Ageusia;Agranulocytosis;Air embolism;Alanine aminotransferase abnormal;Alanine aminotransferase increased;Alcoholic seizure;Allergic bronchopulmonary mycosis;Allergic oedema;Alloimmune hepatitis;Alopecia areata;Alpers disease;Alveolar proteinosis;Ammonia abnormal;Ammonia increased;Amniotic cavity infection;Amygdalohippocampectomy;Amyloid arthropathy;Amyloidosis;Amyloidosis senile;Anaphylactic reaction;Anaphylactic shock;Anaphylactic transfusion reaction;Anaphylactoid reaction;Anaphylactoid shock;Anaphylactoid syndrome of pregnancy;Angioedema;Angiopathic neuropathy;Ankylosing spondylitis;Anosmia;Antiacetylcholine receptor antibody positive;Anti-actin antibody positive;Anti-aquaporin-4 antibody positive;Anti-basal ganglia antibody positive;Anti-cyclic citrullinated peptide antibody positive;Anti-epithelial antibody positive;Anti-erythrocyte antibody positive;Anti-exosome complex antibody positive;Anti- GAD antibody negative;Anti-GAD antibody positive;Anti-ganglioside antibody positive;Antigliadin antibody positive;Anti-glomerular basement membrane antibody positive;Anti-glomerular basement membrane disease;Anti-glycyl-tRNA synthetase antibody positive;Anti-HLA antibody test positive;Anti-IA2 antibody positive;Anti-insulin antibody increased;Anti-insulin antibody positive;Anti-insulin receptor antibody increased;Anti- insulin receptor antibody positive;Anti-interferon antibody negative;Anti-interferon antibody positive;Anti-islet cell antibody positive;Antimitochondrial antibody positive;Anti-muscle specific kinase antibody positive;Anti-myelin-associated glycoprotein antibodies positive;Anti-myelin-associated glycoprotein associated polyneuropathy;Antimyocardial antibody positive;Anti-neuronal antibody positive;Antineutrophil cytoplasmic antibody increased;Antineutrophil cytoplasmic antibody positive;Anti-neutrophil cytoplasmic antibody positive vasculitis;Anti-NMDA antibody positive;Antinuclear antibody increased;Antinuclear antibody positive;Antiphospholipid antibodies positive;Antiphospholipid syndrome;Anti-platelet antibody positive;Anti-prothrombin antibody positive;Antiribosomal P antibody positive;Anti-RNA polymerase III antibody positive;Anti-saccharomyces cerevisiae antibody test positive;Anti-sperm antibody positive;Anti-SRP antibody positive;Antisynthetase syndrome;Anti-thyroid antibody positive;Anti-transglutaminase antibody increased;Anti-VGCC antibody positive;Anti- VGKC antibody positive;Anti-vimentin antibody positive;Antiviral prophylaxis;Antiviral treatment;Anti-zinc transporter 8 antibody positive;Aortic embolus;Aortic thrombosis;Aortitis;Aplasia pure red cell;Aplastic anaemia;Application site thrombosis;Application site vasculitis;Arrhythmia;Arterial bypass occlusion;Arterial bypass thrombosis;Arterial thrombosis;Arteriovenous fistula thrombosis;Arteriovenous graft site stenosis;Arteriovenous graft thrombosis;Arteritis;Arteritis: coronary;Arthralgia;Arthritis;Arthritis enteropathic;Ascites;Aseptic cavernous sinus thrombosis;Aspartate aminotransferase abnormal;Aspartate aminotransferase increased;Aspartate-glutamate-transporter deficiency;AST to platelet ratio index increased;AST/ALT ratio abnormal;Asthma;Asymptomatic COVID- 19;Ataxia;Atheroembolism;Atonic seizures;Atrial thrombosis;Atrophic thyroiditis;Atypical benign partial epilepsy;Atypical pneumonia;Aura;Autoantibody positive;Autoimmune anaemia;Autoimmune aplastic anaemia;Autoimmune arthritis;Autoimmune blistering disease;Autoimmune cholangitis;Autoimmune colitis;Autoimmune demyelinating disease;Autoimmune dermatitis;Autoimmune disorder;Autoimmune encephalopathy;Autoimmune endocrine disorder;Autoimmune enteropathy;Autoimmune eye disorder;Autoimmune haemolytic anaemia;Autoimmune heparin-induced thrombocytopenia;Autoimmune hepatitis;Autoimmune hyperlipidaemia;Autoimmune hypothyroidism;Autoimmune inner ear disease;Autoimmune lung disease;Autoimmune lymphoproliferative syndrome;Autoimmune myocarditis;Autoimmune myositis;Autoimmune nephritis;Autoimmune neuropathy;Autoimmune neutropenia;Autoimmune pancreatitis;Autoimmune pancytopenia;Autoimmune pericarditis;Autoimmune retinopathy;Autoimmune thyroid disorder;Autoimmune thyroiditis;Autoimmune uveitis;Autoinflammation with infantile enterocolitis;Autoinflammatory disease;Automatism epileptic;Autonomic nervous system imbalance;Autonomic seizure;Axial spondyloarthritis;Axillary vein thrombosis;Axonal and demyelinating polyneuropathy;Axonal neuropathy;Bacterascites;Baltic myoclonic epilepsy;Band sensation;Basedow's disease;Basilar artery thrombosis;Basophilopenia;B-cell aplasia;Behcet's syndrome;Benign ethnic neutropenia;Benign familial neonatal convulsions;Benign familial pemphigus;Benign rolandic epilepsy;Beta-2 glycoprotein antibody positive;Bickerstaff's encephalitis;Bile output abnormal;Bile output decreased;Biliary ascites;Bilirubin conjugated abnormal;Bilirubin conjugated increased;Bilirubin urine present;Biopsy liver abnormal;Biotinidase deficiency;Birdshot chorioretinopathy;Blood alkaline phosphatase abnormal;Blood alkaline phosphatase increased;Blood bilirubin abnormal;Blood bilirubin increased;Blood bilirubin unconjugated increased;Blood cholinesterase abnormal;Blood cholinesterase decreased;Blood pressure decreased;Blood pressure diastolic decreased;Blood pressure systolic decreased;Blue toe syndrome;Brachiocephalic vein thrombosis;Brain stem embolism;Brain stem thrombosis;Bromosulphthalein test abnormal;Bronchial oedema;Bronchitis;Bronchitis mycoplasmal;Bronchitis viral;Bronchopulmonary aspergillosis allergic;Bronchospasm;Budd- Chiari syndrome;Bulbar palsy;Butterfly rash;C1q nephropathy;Caesarean section;Calcium embolism;Capillaritis;Caplan's syndrome;Cardiac amyloidosis;Cardiac arrest;Cardiac failure;Cardiac failure acute;Cardiac sarcoidosis;Cardiac ventricular thrombosis;Cardiogenic shock;Cardiolipin antibody positive;Cardiopulmonary failure;Cardio-respiratory arrest;Cardio-respiratory distress;Cardiovascular insufficiency;Carotid arterial embolus;Carotid artery thrombosis;Cataplexy;Catheter site thrombosis;Catheter site vasculitis;Cavernous sinus thrombosis;CDKL5 deficiency disorder;CEC syndrome;Cement embolism;Central nervous system lupus;Central nervous system vasculitis;Cerebellar artery thrombosis;Cerebellar embolism;Cerebral amyloid angiopathy;Cerebral arteritis;Cerebral artery embolism;Cerebral artery thrombosis;Cerebral gas embolism;Cerebral microembolism;Cerebral septic infarct;Cerebral thrombosis;Cerebral venous sinus thrombosis;Cerebral venous thrombosis;Cerebrospinal thrombotic tamponade;Cerebrovascular accident;Change in seizure presentation;Chest discomfort;Child- Pugh-Turcotte score abnormal;Child-Pugh-Turcotte score increased;Chillblains;Choking;Choking sensation;Cholangitis sclerosing;Chronic autoimmune glomerulonephritis;Chronic cutaneous lupus erythematosus;Chronic fatigue syndrome;Chronic gastritis;Chronic inflammatory demyelinating polyradiculoneuropathy;Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids;Chronic recurrent multifocal osteomyelitis;Chronic respiratory failure;Chronic spontaneous urticaria;Circulatory collapse;Circumoral oedema;Circumoral swelling;Clinically isolated syndrome;Clonic convulsion;Coeliac disease;Cogan's syndrome;Cold agglutinins positive;Cold type haemolytic anaemia;Colitis;Colitis erosive;Colitis herpes;Colitis microscopic;Colitis ulcerative;Collagen disorder;Collagen-vascular disease;Complement factor abnormal;Complement factor C1 decreased;Complement factor C2 decreased;Complement factor C3 decreased;Complement factor C4 decreased;Complement factor decreased;Computerised tomogram liver abnormal;Concentric sclerosis;Congenital anomaly;Congenital bilateral perisylvian syndrome;Congenital herpes simplex infection;Congenital myasthenic syndrome;Congenital varicella infection;Congestive hepatopathy;Convulsion in childhood;Convulsions local;Convulsive threshold lowered;Coombs positive haemolytic anaemia;Coronary artery disease;Coronary artery embolism;Coronary artery thrombosis;Coronary bypass thrombosis;Coronavirus infection;Coronavirus test;Coronavirus test negative;Coronavirus test positive;Corpus callosotomy;Cough;Cough variant asthma;COVID-19;COVID-19 immunisation;COVID-19 pneumonia;COVID-19 prophylaxis;COVID-19 treatment;Cranial nerve disorder;Cranial nerve palsies multiple;Cranial nerve paralysis;CREST syndrome;Crohn's disease;Cryofibrinogenaemia;Cryoglobulinaemia;CSF oligoclonal band present;CSWS syndrome;Cutaneous amyloidosis;Cutaneous lupus erythematosus;Cutaneous sarcoidosis;Cutaneous vasculitis;Cyanosis;Cyclic neutropenia;Cystitis interstitial;Cytokine release syndrome;Cytokine storm;De novo purine synthesis inhibitors associated acute inflammatory syndrome;Death neonatal;Deep vein thrombosis;Deep vein thrombosis postoperative;Deficiency of bile secretion;Deja vu;Demyelinating polyneuropathy;Demyelination;Dermatitis;Dermatitis bullous;Dermatitis herpetiformis;Dermatomyositis;Device embolisation;Device related thrombosis;Diabetes mellitus;Diabetic ketoacidosis;Diabetic mastopathy;Dialysis amyloidosis;Dialysis membrane reaction;Diastolic hypotension;Diffuse vasculitis;Digital pitting scar;Disseminated intravascular coagulation;Disseminated intravascular coagulation in newborn;Disseminated neonatal herpes simplex;Disseminated varicella;Disseminated varicella zoster vaccine virus infection;Disseminated varicella zoster virus infection;DNA antibody positive;Double cortex syndrome;Double stranded DNA antibody positive;Dreamy state;Dressler's syndrome;Drop attacks;Drug withdrawal convulsions;Dyspnoea;Early infantile epileptic encephalopathy with burst-suppression;Eclampsia;Eczema herpeticum;Embolia cutis medicamentosa;Embolic cerebellar infarction;Embolic cerebral infarction;Embolic pneumonia;Embolic stroke;Embolism;Embolism arterial;Embolism venous;Encephalitis;Encephalitis allergic;Encephalitis autoimmune;Encephalitis brain stem;Encephalitis haemorrhagic;Encephalitis periaxialis diffusa;Encephalitis post immunisation;Encephalomyelitis;Encephalopathy;Endo crine disorder;Endocrine ophthalmopathy;Endotracheal intubation;Enteritis;Enteritis leukopenic;Enterobacter pneumonia;Enterocolitis;Enteropathic spondylitis;Eosinopenia;Eosinophilic fasciitis;Eosinophilic granulomatosis with polyangiitis;Eosinophilic oesophagitis;Epidermolysis;Epilepsy;Epilepsy surgery;Epilepsy with myoclonic-atonic seizures;Epileptic aura;Epileptic psychosis;Erythema;Erythema induratum;Erythema multiforme;Erythema nodosum;Evans syndrome;Exanthema subitum;Expanded disability status scale score decreased;Expanded disability status scale score increased;Exposure to communicable disease;Exposure to SARS-CoV-2;Eye oedema;Eye pruritus;Eye swelling;Eyelid oedema;Face oedema;Facial paralysis;Facial paresis;Faciobrachial dystonic seizure;Fat embolism;Febrile convulsion;Febrile infection-related epilepsy syndrome;Febrile neutropenia;Felty's syndrome;Femoral artery embolism;Fibrillary glomerulonephritis;Fibromyalgia;Flushing;Foaming at mouth;Focal cortical resection;Focal dyscognitive seizures;Foetal distress syndrome;Foetal placental thrombosis;Foetor hepaticus;Foreign body embolism;Frontal lobe epilepsy;Fulminant type 1 diabetes mellitus;Galactose elimination capacity test abnormal;Galactose elimination capacity test decreased;Gamma-glutamyltransferase abnormal;Gamma-glutamyltransferase increased;Gastritis herpes;Gastrointestinal amyloidosis;Gelastic seizure;Generalised onset non-motor seizure;Generalised tonic-clonic seizure;Genital herpes;Genital herpes simplex;Genital herpes zoster;Giant cell arteritis;Glomerulonephritis;Glomerulonephritis membranoproliferative;Glomerulonephritis membranous;Glomerulonephritis rapidly progressive;Glossopharyngeal nerve paralysis;Glucose transporter type 1 deficiency syndrome;Glutamate dehydrogenase increased;Glycocholic acid increased;GM2 gangliosidosis;Goodpasture's syndrome;Graft thrombosis;Granulocytopenia;Granulocytopenia neonatal;Granulomatosis with polyangiitis;Granulomatous dermatitis;Grey matter heterotopia;Guanase increased;Guillain- Barre syndrome;Haemolytic anaemia;Haemophagocytic lymphohistiocytosis;Haemorrhage;Haemorrhagic ascites;Haemorrhagic disorder;Haemorrhagic pneumonia;Haemorrhagic varicella syndrome;Haemorrhagic vasculitis;Hantavirus pulmonary infection;Hashimoto's encephalopathy;Hashitoxicosis;Hemimegalencephaly;H enoch-Schonlein purpura;Henoch- Schonlein purpura nephritis;Hepaplastin abnormal;Hepaplastin decreased;Heparin-induced thrombocytopenia;Hepatic amyloidosis;Hepatic artery embolism;Hepatic artery flow decreased;Hepatic artery thrombosis;Hepatic enzyme abnormal;Hepatic enzyme decreased;Hepatic enzyme increased;Hepatic fibrosis marker abnormal;Hepatic fibrosis marker increased;Hepatic function abnormal;Hepatic hydrothorax;Hepatic hypertrophy;Hepatic hypoperfusion;Hepatic lymphocytic infiltration;Hepatic mass;Hepatic pain;Hepatic sequestration;Hepatic vascular resistance increased;Hepatic vascular thrombosis;Hepatic vein embolism;Hepatic vein thrombosis;Hepatic venous pressure gradient abnormal;Hepatic venous pressure gradient increased;Hepatitis;Hepatobiliary scan abnormal;Hepatomegaly;Hepatosplenomegaly;Hereditar y angioedema with C1 esterase inhibitor deficiency;Herpes dermatitis;Herpes gestationis;Herpes oesophagitis;Herpes ophthalmic;Herpes pharyngitis;Herpes sepsis;Herpes simplex;Herpes simplex cervicitis;Herpes simplex colitis;Herpes simplex encephalitis;Herpes simplex gastritis;Herpes simplex hepatitis;Herpes simplex meningitis;Herpes simplex meningoencephalitis;Herpes simplex meningomyelitis;Herpes simplex necrotising retinopathy;Herpes simplex oesophagitis;Herpes simplex otitis externa;Herpes simplex pharyngitis;Herpes simplex pneumonia;Herpes simplex reactivation;Herpes simplex sepsis;Herpes simplex viraemia;Herpes simplex virus conjunctivitis neonatal;Herpes simplex visceral;Herpes virus infection;Herpes zoster;Herpes zoster cutaneous disseminated;Herpes zoster infection neurological;Herpes zoster meningitis;Herpes zoster meningoencephalitis;Herpes zoster meningomyelitis;Herpes zoster meningoradiculitis;Herpes zoster necrotising retinopathy;Herpes zoster oticus;Herpes zoster pharyngitis;Herpes zoster reactivation;Herpetic radiculopathy;Histone antibody positive;Hoigne's syndrome;Human herpesvirus 6 encephalitis;Human herpesvirus 6 infection;Human herpesvirus 6 infection reactivation;Human herpesvirus 7 infection;Human herpesvirus 8 infection;Hyperammonaemia;Hyperbilirubinaemia;Hype rcholia;Hypergammaglobulinaemia benign monoclonal;Hyperglycaemic seizure;Hypersensitivity;Hypersensitivity vasculitis;Hyperthyroidism;Hypertransaminasaemia;H yperventilation;Hypoalbuminaemia;H ypocalcaemic seizure;Hypogammaglobulinaemia;Hypoglossal nerve paralysis;Hypoglossal nerve paresis;Hypoglycaemic seizure;Hyponatraemic seizure;Hypotension;Hypotensive crisis;Hypothenar hammer syndrome;Hypothyroidism;Hypoxia;Idiopathic CD4 lymphocytopenia;Idiopathic generalised epilepsy;Idiopathic interstitial pneumonia;Idiopathic neutropenia;Idiopathic pulmonary fibrosis;IgA nephropathy;IgM nephropathy;IIIrd nerve paralysis;IIIrd nerve paresis;Iliac artery embolism;Immune thrombocytopenia;Immune- mediated adverse reaction;Immune-mediated cholangitis;Immune-mediated cholestasis;Immune-mediated cytopenia;Immune-mediated encephalitis;Immune-mediated encephalopathy;Immune-mediated endocrinopathy;Immune-mediated enterocolitis;Immune- mediated gastritis;Immune-mediated hepatic disorder;Immune-mediated hepatitis;Immune- mediated hyperthyroidism;Immune-mediated hypothyroidism;Immune-mediated myocarditis;Immune-mediated myositis;Immune-mediated nephritis;Immune-mediated neuropathy;Immune-mediated pancreatitis;Immune-mediated pneumonitis;Immune-mediated renal disorder;Immune-mediated thyroiditis;Immune-mediated uveitis;Immunoglobulin G4 related disease;Immunoglobulins abnormal;Implant site thrombosis;Inclusion body myositis;Infantile genetic agranulocytosis;Infantile spasms;Infected vasculitis;Infective thrombosis;Inflammation;Inflammatory bowel disease;Infusion site thrombosis;Infusion site vasculitis;Injection site thrombosis;Injection site urticaria;Injection site vasculitis;Instillation site thrombosis;Insulin autoimmune syndrome;Interstitial granulomatous dermatitis;Interstitial lung disease;Intracardiac mass;Intracardiac thrombus;Intracranial pressure increased;Intrapericardial thrombosis;Intrinsic factor antibody abnormal;Intrinsic factor antibody positive;IPEX syndrome;Irregular breathing;IRVAN syndrome;IVth nerve paralysis;IVth nerve paresis;JC polyomavirus test positive;JC virus CSF test positive;Jeavons syndrome;Jugular vein embolism;Jugular vein thrombosis;Juvenile idiopathic arthritis;Juvenile myoclonic epilepsy;Juvenile polymyositis;Juvenile psoriatic arthritis;Juvenile spondyloarthritis;Kaposi sarcoma inflammatory cytokine syndrome;Kawasaki's disease;Kayser-Fleischer ring;Keratoderma blenorrhagica;Ketosis- prone diabetes mellitus;Kounis syndrome;Lafora's myoclonic epilepsy;Lambl's excrescences;Laryngeal dyspnoea;Laryngeal oedema;Laryngeal rheumatoid arthritis;Laryngospasm;Laryngotracheal oedema;Latent autoimmune diabetes in adults;LE cells present;Lemierre syndrome;Lennox-Gastaut syndrome;Leucine aminopeptidase increased;Leukoencephalomyelitis;Leukoencephalopat hy;Leukopenia;Leukopenia neonatal;Lewis-Sumner syndrome;Lhermitte's sign;Lichen planopilaris;Lichen planus;Lichen sclerosus;Limbic encephalitis;Linear IgA disease;Lip oedema;Lip swelling;Liver function test abnormal;Liver function test decreased;Liver function test increased;Liver induration;Liver injury;Liver iron concentration abnormal;Liver iron concentration increased;Liver opacity;Liver palpable;Liver sarcoidosis;Liver scan abnormal;Liver tenderness;Low birth weight baby;Lower respiratory tract herpes infection;Lower respiratory tract infection;Lower respiratory tract infection viral;Lung abscess;Lupoid hepatic cirrhosis;Lupus cystitis;Lupus encephalitis;Lupus endocarditis;Lupus enteritis;Lupus hepatitis;Lupus myocarditis;Lupus myositis;Lupus nephritis;Lupus pancreatitis;Lupus pleurisy;Lupus pneumonitis;Lupus vasculitis;Lupus-like syndrome;Lymphocytic hypophysitis;Lymphocytopenia neonatal;Lymphopenia;MAGIC syndrome;Magnetic resonance imaging liver abnormal;Magnetic resonance proton density fat fraction measurement;Mahler sign;Manufacturing laboratory analytical testing issue;Manufacturing materials issue;Manufacturing production issue;Marburg's variant multiple sclerosis;Marchiafava-Bignami disease;Marine Lenhart syndrome;Mastocytic enterocolitis;Maternal exposure during pregnancy;Medical device site thrombosis;Medical device site vasculitis;MELAS syndrome;Meningitis;Meningitis aseptic;Meningitis herpes;Meningoencephalitis herpes simplex neonatal;Meningoencephalitis herpetic;Meningomyelitis herpes;MERS-CoV test;MERS-CoV test negative;MERS-CoV test positive;Mesangioproliferative glomerulonephritis;Mesenteric artery embolism;Mesenteric artery thrombosis;Mesenteric vein thrombosis;Metapneumovirus infection;Metastatic cutaneous Crohn's disease;Metastatic pulmonary embolism;Microangiopathy;Microembolism;Microscopic polyangiitis;Middle East respiratory syndrome;Migraine-triggered seizure;Miliary pneumonia;Miller Fisher syndrome;Mitochondrial aspartate aminotransferase increased;Mixed connective tissue disease;Model for end stage liver disease score abnormal;Model for end stage liver disease score increased;Molar ratio of total branched-chain amino acid to tyrosine;Molybdenum cofactor deficiency;Monocytopenia;Mononeuritis;Mononeuropat hy multiplex;Morphoea;Morvan syndrome;Mouth swelling;Moyamoya disease;Multifocal motor neuropathy;Multiple organ dysfunction syndrome;Multiple sclerosis;Multiple sclerosis relapse;Multiple sclerosis relapse prophylaxis;Multiple subpial transection;Multisystem inflammatory syndrome in children;Muscular sarcoidosis;Myasthenia gravis;Myasthenia gravis crisis;Myasthenia gravis neonatal;Myasthenic syndrome;Myelitis;Myelitis transverse;Myocardial infarction;Myocarditis;Myocarditis post infection;Myoclonic epilepsy;Myoclonic epilepsy and ragged-red fibres;Myokymia;Myositis;Narcolepsy;Nasal herpes;Nasal obstruction;Necrotising herpetic retinopathy;Neonatal Crohn's disease;Neonatal epileptic seizure;Neonatal lupus erythematosus;Neonatal mucocutaneous herpes simplex;Neonatal pneumonia;Neonatal seizure;Nephritis;Nephrogenic systemic fibrosis;Neuralgic amyotrophy;Neuritis;Neuritis cranial;Neuromyelitis optica pseudo relapse;Neuromyelitis optica spectrum disorder;Neuromyotonia;Neuronal neuropathy;Neuropathy peripheral;Neuropathy, ataxia, retinitis pigmentosa syndrome;Neuropsychiatric lupus;Neurosarcoidosis;Neutropenia;Neutropenia neonatal;Neutropenic colitis;Neutropenic infection;Neutropenic sepsis;Nodular rash;Nodular vasculitis;Noninfectious myelitis;Noninfective encephalitis;Noninfective encephalomyelitis;Noninfective oophoritis;Obstetrical pulmonary embolism;Occupational exposure to communicable disease;Occupational exposure to SARS-CoV-2;Ocular hyperaemia;Ocular myasthenia;Ocular pemphigoid;Ocular sarcoidosis;Ocular vasculitis;Oculofacial paralysis;Oedema;Oedema blister;Oedema due to hepatic disease;Oedema mouth;Oesophageal achalasia;Ophthalmic artery thrombosis;Ophthalmic herpes simplex;Ophthalmic herpes zoster;Ophthalmic vein thrombosis;Optic neuritis;Optic neuropathy;Optic perineuritis;Oral herpes;Oral lichen planus;Oropharyngeal oedema;Oropharyngeal spasm;Oropharyngeal swelling;Osmotic demyelination syndrome;Ovarian vein thrombosis;Overlap syndrome;Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection;Paget-Schroetter syndrome;Palindromic rheumatism;Palisaded neutrophilic granulomatous dermatitis;Palmoplantar keratoderma;Palpable purpura;Pancreatitis;Panencephalitis;Papillophlebi tis;Paracancerous pneumonia;Paradoxical embolism;Parainfluenzae viral laryngotracheobronchitis;Paraneoplastic dermatomyositis;Paraneoplastic pemphigus;Paraneoplastic thrombosis;Paresis cranial nerve;Parietal cell antibody positive;Paroxysmal nocturnal haemoglobinuria;Partial seizures;Partial seizures with secondary generalisation;Patient isolation;Pelvic venous thrombosis;Pemphigoid;Pemphigus;Penile vein thrombosis;Pericarditis;Pericarditis lupus;Perihepatic discomfort;Periorbital oedema;Periorbital swelling;Peripheral artery thrombosis;Peripheral embolism;Peripheral ischaemia;Peripheral vein thrombus extension;Periportal oedema;Peritoneal fluid protein abnormal;Peritoneal fluid protein decreased;Peritoneal fluid protein increased;Peritonitis lupus;Pernicious anaemia;Petit mal epilepsy;Pharyngeal oedema;Pharyngeal swelling;Pityriasis lichenoides et varioliformis acuta;Placenta praevia;Pleuroparenchymal fibroelastosis;Pneumobilia;Pneumonia;Pneumonia adenoviral;Pneumonia cytomegaloviral;Pneumonia herpes viral;Pneumonia influenzal;Pneumonia measles;Pneumonia mycoplasmal;Pneumonia necrotising;Pneumonia parainfluenzae viral;Pneumonia respiratory syncytial viral;Pneumonia viral;POEMS syndrome;Polyarteritis nodosa;Polyarthritis;Polychondritis;Polyglandular autoimmune syndrome type I;Polyglandular autoimmune syndrome type II;Polyglandular autoimmune syndrome type III;Polyglandular disorder;Polymicrogyria;Polymyalgia rheumatica;Polymyositis;Polyneuropathy;Polyneuropa thy idiopathic progressive;Portal pyaemia;Portal vein embolism;Portal vein flow decreased;Portal vein pressure increased;Portal vein thrombosis;Portosplenomesenteric venous thrombosis;Post procedural hypotension;Post procedural pneumonia;Post procedural pulmonary embolism;Post stroke epilepsy;Post stroke seizure;Post thrombotic retinopathy;Post thrombotic syndrome;Post viral fatigue syndrome;Postictal headache;Postictal paralysis;Postictal psychosis;Postictal state;Postoperative respiratory distress;Postoperative respiratory failure;Postoperative thrombosis;Postpartum thrombosis;Postpartum venous thrombosis;Postpericardiotomy syndrome;Post-traumatic epilepsy;Postural orthostatic tachycardia syndrome;Precerebral artery thrombosis;Pre-eclampsia;Preictal state;Premature labour;Premature menopause;Primary amyloidosis;Primary biliary cholangitis;Primary progressive multiple sclerosis;Procedural shock;Proctitis herpes;Proctitis ulcerative;Product availability issue;Product distribution issue;Product supply issue;Progressive facial hemiatrophy;Progressive multifocal leukoencephalopathy;Progressive multiple sclerosis;Progressive relapsing multiple sclerosis;Prosthetic cardiac valve thrombosis;Pruritus;Pruritus allergic;Pseudovasculitis;Psoriasis;Psoriatic arthropathy;Pulmonary amyloidosis;Pulmonary artery thrombosis;Pulmonary embolism;Pulmonary fibrosis;Pulmonary haemorrhage;Pulmonary microemboli;Pulmonary oil microembolism;Pulmonary renal syndrome;Pulmonary sarcoidosis;Pulmonary sepsis;Pulmonary thrombosis;Pulmonary tumour thrombotic microangiopathy;Pulmonary vasculitis;Pulmonary veno-occlusive disease;Pulmonary venous thrombosis;Pyoderma gangrenosum;Pyostomatitis vegetans;Pyrexia;Quarantine;Radiation leukopenia;Radiculitis brachial;Radiologically isolated syndrome;Rash;Rash erythematous;Rash pruritic;Rasmussen encephalitis;Raynaud's phenomenon;Reactive capillary endothelial proliferation;Relapsing multiple sclerosis;Relapsing-remitting multiple sclerosis;Renal amyloidosis;Renal arteritis;Renal artery thrombosis;Renal embolism;Renal failure;Renal vascular thrombosis;Renal vasculitis;Renal vein embolism;Renal vein thrombosis;Respiratory arrest;Respiratory disorder;Respiratory distress;Respiratory failure;Respiratory paralysis;Respiratory syncytial virus bronchiolitis;Respiratory syncytial virus bronchitis;Retinal artery embolism;Retinal artery occlusion;Retinal artery thrombosis;Retinal vascular thrombosis;Retinal vasculitis;Retinal vein occlusion;Retinal vein thrombosis;Retinol binding protein decreased;Retinopathy;Retrograde portal vein flow;Retroperitoneal fibrosis;Reversible airways obstruction;Reynold's syndrome;Rheumatic brain disease;Rheumatic disorder;Rheumatoid arthritis;Rheumatoid factor increased;Rheumatoid factor positive;Rheumatoid factor quantitative increased;Rheumatoid lung;Rheumatoid neutrophilic dermatosis;Rheumatoid nodule;Rheumatoid nodule removal;Rheumatoid scleritis;Rheumatoid vasculitis;Saccadic eye movement;SAPHO syndrome;Sarcoidosis;SARS-CoV-1 test;SARS-CoV-1 test negative;SARS-CoV-1 test positive;SARS-CoV-2 antibody test;SARS-CoV-2 antibody test negative;SARS-CoV-2 antibody test positive;SARS-CoV-2 carrier;SARS-CoV-2 sepsis;SARS-CoV-2 test;SARS- CoV-2 test false negative;SARS-CoV-2 test false positive;SARS-CoV-2 test negative;SARS- CoV-2 test positive;SARS-CoV-2 viraemia;Satoyoshi syndrome;Schizencephaly;Scleritis;Sclerodactylia;S cleroderma;Scleroderma associated digital ulcer;Scleroderma renal crisis;Scleroderma-like reaction;Secondary amyloidosis;Secondary cerebellar degeneration;Secondary progressive multiple sclerosis;Segmented hyalinising vasculitis;Seizure;Seizure anoxic;Seizure cluster;Seizure like phenomena;Seizure prophylaxis;Sensation of foreign body;Septic embolus;Septic pulmonary embolism;Severe acute respiratory syndrome;Severe myoclonic epilepsy of infancy;Shock;Shock symptom;Shrinking lung syndrome;Shunt thrombosis;Silent thyroiditis;Simple partial seizures;Sjogren's syndrome;Skin swelling;SLE arthritis;Smooth muscle antibody positive;Sneezing;Spinal artery embolism;Spinal artery thrombosis;Splenic artery thrombosis;Splenic embolism;Splenic thrombosis;Splenic vein thrombosis;Spondylitis;Spondyloarthropathy;Spontan eous heparin-induced thrombocytopenia syndrome;Status epilepticus;Stevens-Johnson syndrome;Stiff leg syndrome;Stiff person syndrome;Stillbirth;Still's disease;Stoma site thrombosis;Stoma site vasculitis;Stress cardiomyopathy;Stridor;Subacute cutaneous lupus erythematosus;Subacute endocarditis;Subacute inflammatory demyelinating polyneuropathy;Subclavian artery embolism;Subclavian artery thrombosis;Subclavian vein thrombosis;Sudden unexplained death in epilepsy;Superior sagittal sinus thrombosis;Susac's syndrome;Suspected COVID- 19;Swelling;Swelling face;Swelling of eyelid;Swollen tongue;Sympathetic ophthalmia;Systemic lupus erythematosus;Systemic lupus erythematosus disease activity index abnormal;Systemic lupus erythematosus disease activity index decreased;Systemic lupus erythematosus disease activity index increased;Systemic lupus erythematosus rash;Systemic scleroderma;Systemic sclerosis pulmonary;Tachycardia;Tachypnoea;Takayasu's arteritis;Temporal lobe epilepsy;Terminal ileitis;Testicular autoimmunity;Throat tightness;Thromboangiitis obliterans;Thrombocytopenia;Thrombocytopenic purpura;Thrombophlebitis;Thrombophlebitis migrans;Thrombophlebitis
neonatal;Thrombophlebitis septic;Thrombophlebitis superficial;Thromboplastin antibody positive;Thrombosis;Thrombosis corpora cavernosa;Thrombosis in device;Thrombosis mesenteric vessel;Thrombotic cerebral infarction;Thrombotic microangiopathy;Thrombotic stroke;Thrombotic thrombocytopenic purpura;Thyroid disorder;Thyroid stimulating immunoglobulin increased;Thyroiditis;Tongue amyloidosis;Tongue biting;Tongue oedema;Tonic clonic movements;Tonic convulsion;Tonic posturing;Topectomy;Total bile acids increased;Toxic epidermal necrolysis;Toxic leukoencephalopathy;Toxic oil syndrome;Tracheal obstruction;Tracheal oedema;Tracheobronchitis;Tracheobronchitis mycoplasmal;Tracheobronchitis viral;Transaminases abnormal;Transaminases increased;Transfusion-related alloimmune neutropenia;Transient epileptic amnesia;Transverse sinus thrombosis;Trigeminal nerve paresis;Trigeminal neuralgia;Trigeminal palsy;Truncus coeliacus thrombosis;Tuberous sclerosis complex;Tubulointerstitial nephritis and uveitis syndrome;Tumefactive multiple sclerosis;Tumour embolism;Tumour thrombosis;Type 1 diabetes mellitus;Type I hypersensitivity;Type III immune complex mediated reaction;Uhthoff's phenomenon;Ulcerative keratitis;Ultrasound liver abnormal;Umbilical cord thrombosis;Uncinate fits;Undifferentiated connective tissue disease;Upper airway obstruction;Urine bilirubin increased;Urobilinogen urine decreased;Urobilinogen urine increased;Urticaria;Urticaria papular;Urticarial vasculitis;Uterine rupture;Uveitis;Vaccination site thrombosis;Vaccination site vasculitis;Vagus nerve paralysis;Varicella;Varicella keratitis;Varicella post vaccine;Varicella zoster gastritis;Varicella zoster oesophagitis;Varicella zoster pneumonia;Varicella zoster sepsis;Varicella zoster virus infection;Vasa praevia;Vascular graft thrombosis;Vascular pseudoaneurysm thrombosis;Vascular purpura;Vascular stent thrombosis;Vasculitic rash;Vasculitic ulcer;Vasculitis;Vasculitis gastrointestinal;Vasculitis necrotising;Vena cava embolism;Vena cava thrombosis;Venous intravasation;Venous recanalisation;Venous thrombosis;Venous thrombosis in pregnancy;Venous thrombosis limb;Venous thrombosis neonatal;Vertebral artery thrombosis;Vessel puncture site thrombosis;Visceral venous thrombosis;VIth nerve paralysis;VIth nerve paresis;Vitiligo;Vocal cord paralysis;Vocal cord paresis;Vogt-Koyanagi-Harada disease;Warm type haemolytic anaemia;Wheezing;White nipple sign;XIth nerve paralysis;X-ray hepatobiliary abnormal;Young's syndrome;Zika virus associated Guillain Barre syndrome.
CONFIDENTIAL Page 9
FDA-CBER-2021-5683-0000091
sharon sanders
Editor-in-Chief & President
I think appendix 1 is a list of side that the company was MONITORING for - not the effects that occurred. As I understand it, this is now a public document published by the FDA in their CBER program for 2022. Also, a judge ordered release of some documents. https://www.fda.gov/vaccines-blood-...er-planning-publish-during-calendar-year-2022
sharon sanders
Editor-in-Chief & President
A pro-vaccine analysis of the above. Like I have said many times - we are going to publish all sides of an issue. We do not do cancel culture.
IF YOU HAVE ANY MEDICAL QUESTIONS, INCLUDING VACCINES, CONSULT YOUR MEDICAL PRACTITIONER.
Edward Nirenberg
@ENirenberg
I see a lot of people sharing a document from Pfizer describing pharmacovigilance data from spontaneous reporting and the vast, vast majority of people are not interpreting it correctly so here's a thread on what it actually says.
https://phmpt.org/wp-content/uploads...nce.pdf…9:49 PM · Mar 1, 2022
This document describes the post-marketing data of the Pfizer vaccine voluntarily (spontaneously) reported to Pfizer as of February 29, 2021, at which point MILLIONS of people had been vaccinated. The US alone was averaging 2 million doses of vaccine per day at that point.
We need to get some definitions out of the way or we won't get anywhere (this is dry- sorry). I'll limit this to important ones from the abbreviations.
Adverse events (AEs) do not mean what you (probably) think they do. AEs ≠ side effects.
https://fda.gov/media/93884/download
AEs are monitored regardless of whether you get the active agent or the placebo in a trial, and that information may be reported in e.g. package inserts. E.g. Gardasil has a report on its package insert of gunshot wounds as an AE. Need I explain that it doesn't cause them?
In many clinical trial designs, there is blinding, so you don't know in advance whether or not you get placebo or active agent so you monitor everyone. Additionally, the placebo group helps you to see what is normal for similar people at similar times in similar places.
Formally, what most people think of as a side effect is more properly described as an adverse drug reaction (ADR), and for formal purposes the term "side effect" is best avoided altogether:
https://ema.europa.eu/en/documents/s...e_en-15.pdf…
However, it can be very hard to tease apart what is AE vs. ADR.
AEs can be classified as serious or non-serious. These also have very specific definitions. There is also the term "life-threatening adverse event" which has a very specific meaning.
"AE of special interest" is a term that appears here (commonly abbreviated AESI). These are literally just adverse events that it's just especially important to track or monitor. That could be because they're serious, because of something about how the drug works...
or how related drugs work, or because of how significant it is as a problem. If an AESI occurs, the sponsor (the pharmaceutical company paying for the trial) generally needs to be alerted of it rapidly. https://cioms.ch/wp-content/uploads/2017/01/Mgment_Safety_Info.pdf
AESIs get specified in protocols, generally before the trial has even begun, although protocols can be amended to include new AESIs as data emerges. In other words, that big scary list in Appendix 1 that people are claiming are side effects of the Pfizer vaccine? Blatant lie. (My bolding here. s.s.)
That list alone tells us nothing about whether or not any of those things happened to anyone in the dataset. They are just things Pfizer wrote in the protocol to be watched for as AESIs. Now, onto the data:
Because this information is reported spontaneously (voluntarily), we don't have knowledge of denominators (the same issue as VAERS: https://deplatformdisease.com/blog/an-overview-of-us-vaccine-pharmacovigilance?rq=VAERS…) and so the uses and limitations of these data are similar to VAERS's.
In other words the main value of this data is if it identifies a significant spike in a particular AE, you can do a more granular analysis in a more rigorous pharmacovigilance system like the VSD. So, what did it find?
Table 2 discusses AEs found in more than 2% of individuals. I couldn't find a serious one; most describe reactogenicity symptoms- things that indicate that the immune system is generating a response to the vaccine. They are unpleasant, but temporary and are not a safety concern.
Much of the information in this document is now redundant or irrelevant because of real-world data. Table 4 discusses the detailed findings for anaphylaxis but doesn't allow us to estimate a rate. Today that rate looks to be somewhere around 1 per 200,000 vaccine doses.
Table 5 has to do with important potential risks, e.g. VAERD (vaccine-associated enhanced respiratory disease) where COVID-19 becomes more severe in vaccinated people. This has not been observed and there is significant evidence to the contrary e.g.
Table 6 is about missing information e.g. use of the vaccine in pregnant individuals or in children. This is outdated- we now know quite clearly that vaccination for both groups is safe and essential. The vaccine can also be given without interrupting breastfeeding.
Table 7 is the big scary table going through the AESIs captured by spontaneous reporting. None generated a signal, meaning they do not occur appreciably more frequently than the background rate in this dataset. While they may be underreported, this is less likely for serious AEs.
There is then a section on medication errors. 7 deaths were reported but the footnote explains that there is no clear link between the vaccination and the death in these cases. Watch millions of people for a few months and a bunch of them will die. Some things are coincidence.
Table 8 goes into the details. Anyway, what does this report actually tell us? There was no clear indication of any kind of substantial safety problem with the Pfizer/BioNTech COVID-19 vaccine as of February 29, 2021. Let's stop misrepresenting these documents henceforth.
I will add that this document did not identify a signal for myocarditis (though it was an AESI); this is likely related to the fact that the condition is mainly limited to younger males and few had been receiving the vaccine at the point the analysis was done.
Also my b- it's supposed to be through February 28, 2021 (there is no February 29, 2021; I misread the dates).
Edward Nirenberg@ENirenberg·6hReplying to @ENirenberg
Going to add this- I didn’t bother with a rigorous estimate of how many doses were given but this is a good way to put things into perspective:Quote
TweetJames
Neill - 
@jneill · 9hReplying to @ENirenberg
Also a hot (incorrect) take is 1,223 fatal from 42,086 cases...
But denominator should be number of doses, not number of reports. Doses were redacted from the document but are estimated at 119 million.
And of course most fatalities are only temporally connected, not causatively
-------------------------------------------------------------------------------------------------------
I have no idea from where Nirenberg receives $.
"Nirenberg majored in biochemistry at Cornell University, earning a bachelor of science degree in 2019. He also took immunology courses, worked as a lab research assistant, and learned about the anti-vaccine culture that has often challenged public health.
After graduating, he worked briefly as a medical scribe for a urology office and emergency department in New York City. But when COVID forced shutdowns, Nirenberg lost his job. He began blogging in November 2020, and a month later, he said he already had a following."
snip
"Earlier this year, Risa Hoshino, MD, a New York City pediatrician, started reading his work and contacted him.
"He knows what he's talking about," Hoshino told MedPage Today. He also has the "unique ability" to communicate scientific topics well to both science and lay audiences, she added.
Hoshino vetted him, she said, just as she vets any potential collaborator. Not only is he passionate, but "he has original ideas, he writes really well," she noted.
They co-authored an opinion piece calling childhood COVID a "crisis" for MedPage Today in mid-June, with Nirenberg listed as the lead author.
Both are part of "a grassroots community of vaccination advocates," said collaborator Daniel Freedman, DO, a pediatric neurologist based in Austin, Texas. They teamed with a few others to write a column about vaccination in kids for a BMJ blog, which was published online later in June.
Nirenberg was identified as "a science communicator and vaccine advocate" by the journal. He wrote an equal portion of the piece, Freedman said.
"I think he is a very strong science communicator, he has a very, very good understanding of basic science," Freedman added."
more...
https://www.medpagetoday.com/special...clusives/96262
IF YOU HAVE ANY MEDICAL QUESTIONS, INCLUDING VACCINES, CONSULT YOUR MEDICAL PRACTITIONER.
Edward Nirenberg
@ENirenbergI see a lot of people sharing a document from Pfizer describing pharmacovigilance data from spontaneous reporting and the vast, vast majority of people are not interpreting it correctly so here's a thread on what it actually says.
https://phmpt.org/wp-content/uploads...nce.pdf…9:49 PM · Mar 1, 2022
This document describes the post-marketing data of the Pfizer vaccine voluntarily (spontaneously) reported to Pfizer as of February 29, 2021, at which point MILLIONS of people had been vaccinated. The US alone was averaging 2 million doses of vaccine per day at that point.
We need to get some definitions out of the way or we won't get anywhere (this is dry- sorry). I'll limit this to important ones from the abbreviations.
Adverse events (AEs) do not mean what you (probably) think they do. AEs ≠ side effects.
https://fda.gov/media/93884/download
AEs are monitored regardless of whether you get the active agent or the placebo in a trial, and that information may be reported in e.g. package inserts. E.g. Gardasil has a report on its package insert of gunshot wounds as an AE. Need I explain that it doesn't cause them?
In many clinical trial designs, there is blinding, so you don't know in advance whether or not you get placebo or active agent so you monitor everyone. Additionally, the placebo group helps you to see what is normal for similar people at similar times in similar places.
Formally, what most people think of as a side effect is more properly described as an adverse drug reaction (ADR), and for formal purposes the term "side effect" is best avoided altogether:
https://ema.europa.eu/en/documents/s...e_en-15.pdf…
However, it can be very hard to tease apart what is AE vs. ADR.
AEs can be classified as serious or non-serious. These also have very specific definitions. There is also the term "life-threatening adverse event" which has a very specific meaning.
"AE of special interest" is a term that appears here (commonly abbreviated AESI). These are literally just adverse events that it's just especially important to track or monitor. That could be because they're serious, because of something about how the drug works...
or how related drugs work, or because of how significant it is as a problem. If an AESI occurs, the sponsor (the pharmaceutical company paying for the trial) generally needs to be alerted of it rapidly. https://cioms.ch/wp-content/uploads/2017/01/Mgment_Safety_Info.pdf
AESIs get specified in protocols, generally before the trial has even begun, although protocols can be amended to include new AESIs as data emerges. In other words, that big scary list in Appendix 1 that people are claiming are side effects of the Pfizer vaccine? Blatant lie. (My bolding here. s.s.)
That list alone tells us nothing about whether or not any of those things happened to anyone in the dataset. They are just things Pfizer wrote in the protocol to be watched for as AESIs. Now, onto the data:
Because this information is reported spontaneously (voluntarily), we don't have knowledge of denominators (the same issue as VAERS: https://deplatformdisease.com/blog/an-overview-of-us-vaccine-pharmacovigilance?rq=VAERS…) and so the uses and limitations of these data are similar to VAERS's.
In other words the main value of this data is if it identifies a significant spike in a particular AE, you can do a more granular analysis in a more rigorous pharmacovigilance system like the VSD. So, what did it find?
Table 2 discusses AEs found in more than 2% of individuals. I couldn't find a serious one; most describe reactogenicity symptoms- things that indicate that the immune system is generating a response to the vaccine. They are unpleasant, but temporary and are not a safety concern.
Much of the information in this document is now redundant or irrelevant because of real-world data. Table 4 discusses the detailed findings for anaphylaxis but doesn't allow us to estimate a rate. Today that rate looks to be somewhere around 1 per 200,000 vaccine doses.
Table 5 has to do with important potential risks, e.g. VAERD (vaccine-associated enhanced respiratory disease) where COVID-19 becomes more severe in vaccinated people. This has not been observed and there is significant evidence to the contrary e.g.
Table 6 is about missing information e.g. use of the vaccine in pregnant individuals or in children. This is outdated- we now know quite clearly that vaccination for both groups is safe and essential. The vaccine can also be given without interrupting breastfeeding.
Table 7 is the big scary table going through the AESIs captured by spontaneous reporting. None generated a signal, meaning they do not occur appreciably more frequently than the background rate in this dataset. While they may be underreported, this is less likely for serious AEs.
There is then a section on medication errors. 7 deaths were reported but the footnote explains that there is no clear link between the vaccination and the death in these cases. Watch millions of people for a few months and a bunch of them will die. Some things are coincidence.
Table 8 goes into the details. Anyway, what does this report actually tell us? There was no clear indication of any kind of substantial safety problem with the Pfizer/BioNTech COVID-19 vaccine as of February 29, 2021. Let's stop misrepresenting these documents henceforth.
I will add that this document did not identify a signal for myocarditis (though it was an AESI); this is likely related to the fact that the condition is mainly limited to younger males and few had been receiving the vaccine at the point the analysis was done.
Also my b- it's supposed to be through February 28, 2021 (there is no February 29, 2021; I misread the dates).
Edward Nirenberg
@ENirenberg·6hReplying to @ENirenbergGoing to add this- I didn’t bother with a rigorous estimate of how many doses were given but this is a good way to put things into perspective:Quote
TweetJames
Neill - @jneill · 9hReplying to @ENirenbergAlso a hot (incorrect) take is 1,223 fatal from 42,086 cases...
But denominator should be number of doses, not number of reports. Doses were redacted from the document but are estimated at 119 million.
And of course most fatalities are only temporally connected, not causatively
-------------------------------------------------------------------------------------------------------
I have no idea from where Nirenberg receives $.
"Nirenberg majored in biochemistry at Cornell University, earning a bachelor of science degree in 2019. He also took immunology courses, worked as a lab research assistant, and learned about the anti-vaccine culture that has often challenged public health.
After graduating, he worked briefly as a medical scribe for a urology office and emergency department in New York City. But when COVID forced shutdowns, Nirenberg lost his job. He began blogging in November 2020, and a month later, he said he already had a following."
snip
"Earlier this year, Risa Hoshino, MD, a New York City pediatrician, started reading his work and contacted him.
"He knows what he's talking about," Hoshino told MedPage Today. He also has the "unique ability" to communicate scientific topics well to both science and lay audiences, she added.
Hoshino vetted him, she said, just as she vets any potential collaborator. Not only is he passionate, but "he has original ideas, he writes really well," she noted.
They co-authored an opinion piece calling childhood COVID a "crisis" for MedPage Today in mid-June, with Nirenberg listed as the lead author.
Both are part of "a grassroots community of vaccination advocates," said collaborator Daniel Freedman, DO, a pediatric neurologist based in Austin, Texas. They teamed with a few others to write a column about vaccination in kids for a BMJ blog, which was published online later in June.
Nirenberg was identified as "a science communicator and vaccine advocate" by the journal. He wrote an equal portion of the piece, Freedman said.
"I think he is a very strong science communicator, he has a very, very good understanding of basic science," Freedman added."
more...
https://www.medpagetoday.com/special...clusives/96262
sharon sanders
Editor-in-Chief & President
Please see post #120 below for rebuttal.
GardenSpider
Well-known member
Interesting. Thank you for posting this explanation. There may be others.
It seemed likely to be their list of adverse reactions given their use of fraudulent data sets that obscured vaccine injuries and deaths related to the vaccine.
It seemed likely to be their list of adverse reactions given their use of fraudulent data sets that obscured vaccine injuries and deaths related to the vaccine.
GardenSpider
Well-known member
From the Canadian CoVid Care Alliance.
PFIZER DATA PROVES THEIR INOCULATIONS DO MORE HARM THAN GOOD
https://www.canadiancovidcareallianc...ec-16-2021.pdf
See the video here that goes over the material from the trials.
https://rumble.com/vqx3kb-the-pfizer...than-good.html
The material describes how the process of the phase studies of the vaccine was abridged in 2 months not the 3-years the study was designed for, with the study blinds removed and candidates on placebo being allowed to switch to the vaccine group too soon for scientific study reliability. This means that “for the rest of the trial there was no way to access efficacy or safety.”
The thought-provoking documentary further explains that when Pfizer announced 95% efficacy of its vaccine, this claim was based on “relative risk” and not “absolute risk,” the more useful scientific term. Claiming Pfizer misled the public, the document explains that overall the Pfizer vaccine was able to reduce the risk of covid disease from a fraction of 0.84% (without vaccine use) to 0.04% (with vaccine use), the difference being the relative risk 95% advantage.
In the trial, 8 out of 18,198 given vaccine developed covid-19, that’s 0.04%, vs 162 in placebo group or 0.88%. The difference of 0.84% being pushed to the public as the 0.84% gain or 95% efficacy.
‘The number does not mean the vaccine protects you 95% of the time. The FDA recommends using absolute risk.’
The group explained that the public was more interested in the absolute risk reduction and benefit of the shots, which would be a mere 0.84%. This considered with the many side-effect reported risks of the vaccine by itself paints a picture of a high risk, low benefit intervention not reflected in the 95% efficacy advertisement.
“There is no benefit to a reduction in cases if it comes at the cost of increased sickness and death”
‘The inoculated arm showed an increase in adverse events in almost every category, eg, there were almost 5000 in the experimental arm and just over 1000 in the placebo arm.'
GardenSpider
Well-known member
Interestingly, I found this interview with mathematician Philip Tomlinson who lectured in data organization and control.
I don't think it can be determined that the Pfizer data supports their claim the vaccines are safe. He says the data doesn't stack up.
See his explanation that raises serious questions.
https://www.bitchute.com/video/GXxMklS3rPIh/
I don't think it can be determined that the Pfizer data supports their claim the vaccines are safe. He says the data doesn't stack up.
See his explanation that raises serious questions.
https://www.bitchute.com/video/GXxMklS3rPIh/
GardenSpider
Well-known member
Dr. Edward Nirenberg is a 20s something medical blogger who graduated from the school of agriculture and life sciences. He is a young social media influencer who uses these platforms to "bust myths" that promote vaccine hesitancy. He is pro-vaccine and clearly doesn't have any understanding of how they could be, and are dangerous. He says, "I have a bigger audience now (still don’t get how that happened) than I’m used to so I need to clarify some things about me. Firstly, I am not a public health expert, nor an expert on COVID-19, pandemics generally, virology, infectious disease, or medicine.— Edward Nirenberg (@ENirenberg) December 20, 2020
Everything that I have found online confirms the position that the Pfizer data shows the shot to be dangerous to human health.
Edward has oversimplified the explanations, when no such inferences can be made given the data points. Many skilled knowledgable, and experienced professionals are pouring over the Pfizer data and what they have to say is damning to say the least.
https://newsrescue.com/1200-deaths-...rcement-and-its-not-good-expert-video-review/
Everything that I have found online confirms the position that the Pfizer data shows the shot to be dangerous to human health.
Edward has oversimplified the explanations, when no such inferences can be made given the data points. Many skilled knowledgable, and experienced professionals are pouring over the Pfizer data and what they have to say is damning to say the least.
https://newsrescue.com/1200-deaths-...rcement-and-its-not-good-expert-video-review/
GardenSpider
Well-known member
1200 Deaths in 90 Days!: Pfizer Safety Data Released Under Judge FOIA Enforcement, “And It’s Not Good”
https://newsrescue.com/1200-deaths-...rcement-and-its-not-good-expert-video-review/
https://www.youtube.com/watch?v=wCbohvmiigY&feature=emb_imp_woyt
Episode 038
00:00 – Intro
02:17 – Pfizer Safety Data “Leaked”
09:38 – Known Limitations of SAEs
12:59 – Issues Immediately Apparent in Table 1
21:32 – Safety: Preganancy
24:08 – Children – Off Label Use
27:09 – Heart Issues (Known by Feb 28, 2021)
31:15 – Immune-Mediated
33:34 – Informed Consent
40:44 – What is “informed Consent” for Pregnancy?
43:00 – Conclusions
by Chris Martenson, PeakProsperity
This episode reviews a previously hidden report by Pfizer to the FDA covering the first 90 days of ‘post authorization’ vaccine safety data. A judge ordered its release and, perhaps not surprisingly, no major news outlet has dared to cover the story.
Within that first 90- day window, over 1,200 deaths were reported, with a significant number appearing to happen within the first 24 hours after vaccination. We can’t say for sure because the report lacks critical details that would allow us to align the specific deaths with the reported observation that the median elapsed time between vaccination and the adverse event was “<24 hours” for many types of AEs.
This report is a ‘second go’ by Pfizer after the first report was deemed wholly insufficient and lacking detail. This one isn’t actually all that much better, as it is entirely passive (no active data collection undertaken – it relies entirely on “spontaneously” reported events, and no inquiry into the adverse events is part of this version of the report), there’s no attempt made to define the incidence of events, and there is no visible effort made to compare the levels of events to an expected baseline of such events.
It is also impossible to determine first vs second vaccination injections (not reported) and the age brackets are not even age brackets (“child, adult and elderly”).
Besides the 1,223 spontaneously reported deaths, there is an overwhelming tilt towards women reporting AE’s often on the order of 4x or more. None of these were deemed to be worthy of modifying either the administration of the vaccines or the collection of new data in more useful detail.
Further, I track down the actual state of knowledge of what is and is not known about pregnancy and the vaccines to uncover the fact that no providers can say, one way or the other, if the vaccines are safe.
In the most current language available to vaccinators and health care providers, Pfizer says “Available data on COMIRNATY administered to pregnant women are insufficient to inform vaccine-associated risks in pregnancy.”
https://newsrescue.com/1200-deaths-...rcement-and-its-not-good-expert-video-review/
https://www.youtube.com/watch?v=wCbohvmiigY&feature=emb_imp_woyt
Episode 038
00:00 – Intro
02:17 – Pfizer Safety Data “Leaked”
09:38 – Known Limitations of SAEs
12:59 – Issues Immediately Apparent in Table 1
21:32 – Safety: Preganancy
24:08 – Children – Off Label Use
27:09 – Heart Issues (Known by Feb 28, 2021)
31:15 – Immune-Mediated
33:34 – Informed Consent
40:44 – What is “informed Consent” for Pregnancy?
43:00 – Conclusions
by Chris Martenson, PeakProsperity
This episode reviews a previously hidden report by Pfizer to the FDA covering the first 90 days of ‘post authorization’ vaccine safety data. A judge ordered its release and, perhaps not surprisingly, no major news outlet has dared to cover the story.
Within that first 90- day window, over 1,200 deaths were reported, with a significant number appearing to happen within the first 24 hours after vaccination. We can’t say for sure because the report lacks critical details that would allow us to align the specific deaths with the reported observation that the median elapsed time between vaccination and the adverse event was “<24 hours” for many types of AEs.
This report is a ‘second go’ by Pfizer after the first report was deemed wholly insufficient and lacking detail. This one isn’t actually all that much better, as it is entirely passive (no active data collection undertaken – it relies entirely on “spontaneously” reported events, and no inquiry into the adverse events is part of this version of the report), there’s no attempt made to define the incidence of events, and there is no visible effort made to compare the levels of events to an expected baseline of such events.
It is also impossible to determine first vs second vaccination injections (not reported) and the age brackets are not even age brackets (“child, adult and elderly”).
Besides the 1,223 spontaneously reported deaths, there is an overwhelming tilt towards women reporting AE’s often on the order of 4x or more. None of these were deemed to be worthy of modifying either the administration of the vaccines or the collection of new data in more useful detail.
Further, I track down the actual state of knowledge of what is and is not known about pregnancy and the vaccines to uncover the fact that no providers can say, one way or the other, if the vaccines are safe.
In the most current language available to vaccinators and health care providers, Pfizer says “Available data on COMIRNATY administered to pregnant women are insufficient to inform vaccine-associated risks in pregnancy.”
Emily
Editor, Senior Moderator
SV40 all over again. Clusters of toddlers with unusual brain tumors.
https://www.mdpi.com/1467-3045/44/3/73/htm#B39-cimb-44-00073
https://www.investorvillage.com/smbd.asp?mb=19816&mn=46069&pt=msg&mid=22979508
https://www.mdpi.com/1467-3045/44/3/73/htm#B39-cimb-44-00073
https://www.investorvillage.com/smbd.asp?mb=19816&mn=46069&pt=msg&mid=22979508
Emily
Editor, Senior Moderator
Stefan Oelrich of Bayer is quoted. Video at link.
https://twitter.com/MichaelPSenger/status/1499525335762620416
Michael P Senger @MichaelPSenger
World Health Summit: “If we had surveyed two years ago…‘Would you be willing to take gene or cell therapy and inject it into your body?’ we would have probably had a 95% refusal rate. I think this pandemic has opened many people’s eyes to innovation.”
461.9K views
0:07 / 0:41
https://twitter.com/MichaelPSenger/status/1499525335762620416
From Covid-1984
5:21 PM · Mar 3, 2022·Twitter Web App
https://twitter.com/MichaelPSenger/status/1499525335762620416
Michael P Senger @MichaelPSenger
World Health Summit: “If we had surveyed two years ago…‘Would you be willing to take gene or cell therapy and inject it into your body?’ we would have probably had a 95% refusal rate. I think this pandemic has opened many people’s eyes to innovation.”
461.9K views
0:07 / 0:41
https://twitter.com/MichaelPSenger/status/1499525335762620416
From Covid-1984
5:21 PM · Mar 3, 2022·Twitter Web App
Emily
Editor, Senior Moderator
See - VAERS is 'cleaned up' by the CDC.
https://www.icandecide.org/ican_pre...-from-vaers-and-cdc-has-no-records-as-to-why/
Mar 04, 2022, 18:23ET
On December 16, 2021, ICAN, through its attorneys, issued a Freedom of Information Act request to the CDC seeking any documents reflecting why a certain VAERS report was no longer available in the VAERS database. The report described an extremely disturbing incident wherein a two-year-old boy “began bleeding out of the mouth, eyes, nose and ears within six hours” of his first dose of Pfizer’s COVID-19 vaccine on November 18, 2021, and died later that night. On February 14, 2022, the CDC finally responded to ICAN’s request, stating: “A search of our records failed to reveal any documents pertaining to your request.”...
https://www.icandecide.org/ican_pre...-from-vaers-and-cdc-has-no-records-as-to-why/
Mar 04, 2022, 18:23ET
On December 16, 2021, ICAN, through its attorneys, issued a Freedom of Information Act request to the CDC seeking any documents reflecting why a certain VAERS report was no longer available in the VAERS database. The report described an extremely disturbing incident wherein a two-year-old boy “began bleeding out of the mouth, eyes, nose and ears within six hours” of his first dose of Pfizer’s COVID-19 vaccine on November 18, 2021, and died later that night. On February 14, 2022, the CDC finally responded to ICAN’s request, stating: “A search of our records failed to reveal any documents pertaining to your request.”...
Pathfinder
Editor, Senior Moderator
CITATION: J.N. v. C.G., 2022 ONSC 1198
COURT FILE NO.: 987/18
DATE: 2022-02-22
ONTARIO
SUPERIOR COURT OF JUSTICE
BETWEEN:
J.N.
Applicant
– and –
C.G.
Respondent
Self-Represented
Jesse Herman, Counsel, for the Respondent
HEARD: February 18, 2022
JUDGMENT
THE HONOURABLE MR. JUSTICE A. PAZARATZ
[1] When did it become illegal to ask questions? Especially in the courtroom?
[2] And when did it become unfashionable for judges to receive answers? Especially when
children’s lives are at stake?
[3] How did we lower our guard and let the words “unacceptable beliefs” get paired together?
In a democracy? On the Scales of Justice?
[4] Should judges sit back as the concept of “Judicial Notice” gets hijacked from a rule of
evidence to a substitute for evidence
[5] And is “misinformation” even a real word? Or has it become a crass, self-serving tool to
pre-empt scrutiny and discredit your opponent? To de-legitimize questions and
strategically avoid giving answers. Blanket denials are almost never acceptable in our
adversarial system. Each party always has the onus to prove their case and yet
“misinformation” has crept into the court lexicon. A childish – but sinister – way of saying
“You’re so wrong, I don’t even have to explain why you’re wrong.”
[6] What does any of this have to do with family court? Sadly, these days it has everything to
do with family court.
[7] Because when society demonizes and punishes anyone who disagrees – or even dares to
ask really important questions – the resulting polarization, disrespect, and simmering anger
can have devastating consequences for the mothers, fathers and children I deal with on a
daily basis.\
[8] It’s becoming harder for family court judges to turn enemies into friends -- when
governments are so recklessly turning friends into enemies.
[9] The motion before me is a typical – and frightening – example of how far we are drifting
from cherished values.
[10] The father wants two children ages 12 and 10 to receive COVID vaccinations. The mother
is opposed.
[11] Now, answer honestly. Did the previous paragraph give you enough information to form
an opinion about how this case should turn out?
[12] We’re all weary. We all wish COVID would just go away. But pandemic fatigue is no
excuse for short-cuts and lowering our standards. We all have to guard against the
unconscious bias of thinking “Why won’t these people just do what the government tells
them to do?”
[13] We have to decide on the basis of the best interests of each particular child in each
particular fact situation.
[14] We have to rely on – and insist upon – evidence.
[15] In this case the evidence provided more questions than answers.
a. The father filed two affidavits.
b. The mother filed one.
c. They both relied extensively on unsworn “exhibits”, which were basically
internet downloads.
d. In addition, the father relied on numerous downloads from the mother’s
social media accounts.
e. They both consented to my receiving these materials, to demonstrate the
sources of information which each of them is relying on in formulating their
respective parenting position.
...
[80] This is not the kind of case where the court can say that either side is necessarily correct.
Nor that the same determinations should apply for every child, no matter the circumstances.
[81] With the mother’s materials satisfying me that a legitimate and highly complex debate
exists on the efficacy and utilization of COVID vaccines, I am not prepared to apply
judicial notice as a method of resolving the issue. Anyone reading even some of the articles
presented by the mother would likely conclude that these are complicated and evolving
issues, and there can be no simplistic presumption that one side is right and that the other
side is comprised of a bunch of crackpots. That’s why the court should require evidence
rather than conclusory statements.
[82] The father insists the mother’s views have been debunked, but he provides no example of
any such determination actually having been made. It would be helpful if, once and for
all, the competing positions and science could be properly explored and tested in a public
trial.
[83] On balance, I am satisfied that that mother’s request for a cautious approach is compelling,
and reinforced by the children’s views and preferences which are legitimate and must be
respected. The mother has consistently made excellent decisions throughout the children’s
lives. Her current concerns about the vaccines are entirely understandable, given the
credible warnings and commentary provided by reputable sources who are specifically
acquainted with this issue.
[84] The mother has consistently made excellent, informed, and child-focussed decisions. In
every respect she is an exemplary parent, fully attuned to her children’s physical and
emotional needs. She has demonstrated a clear understanding of the science. She has
raised legitimate questions and concerns. I have confidence that she will continue to seek
out answers to safeguard the physical and emotional health of her children.
[85] She is not a bad parent – and no one is a bad citizen – simply by virtue of asking questions
of the government.
[86] At a certain point, where you have absolute confidence in a parent’s insight and decisionmaking, you have to
step back and acknowledge that they love their child; they have always
done the right thing for their child...and they will continue to do the right thing for their
child.
[87] The father’s motion is dismissed.
[88] The mother shall have sole decision-making authority with respect to the issue of
administering COVID vaccines for the children L.E.G. and M.D.G..
...
POSTSCRIPT:
[91] It’s irrelevant to my decision and it’s none of anyone’s business.
[92] But I am fully vaccinated. My choice.
[93] I mention this because I am acutely aware of how polarized the world has become.
[94] We should all return to discussing the issues rather than making presumptions about one
another
Pazaratz J.
Released: February 22, 2022
...
Full text (28 pages):
https://www.sirillp.com/wp-content/uploads/2022/03/Ontario-Family-Court-decision.pdf
COURT FILE NO.: 987/18
DATE: 2022-02-22
ONTARIO
SUPERIOR COURT OF JUSTICE
BETWEEN:
J.N.
Applicant
– and –
C.G.
Respondent
Self-Represented
Jesse Herman, Counsel, for the Respondent
HEARD: February 18, 2022
JUDGMENT
THE HONOURABLE MR. JUSTICE A. PAZARATZ
[1] When did it become illegal to ask questions? Especially in the courtroom?
[2] And when did it become unfashionable for judges to receive answers? Especially when
children’s lives are at stake?
[3] How did we lower our guard and let the words “unacceptable beliefs” get paired together?
In a democracy? On the Scales of Justice?
[4] Should judges sit back as the concept of “Judicial Notice” gets hijacked from a rule of
evidence to a substitute for evidence
[5] And is “misinformation” even a real word? Or has it become a crass, self-serving tool to
pre-empt scrutiny and discredit your opponent? To de-legitimize questions and
strategically avoid giving answers. Blanket denials are almost never acceptable in our
adversarial system. Each party always has the onus to prove their case and yet
“misinformation” has crept into the court lexicon. A childish – but sinister – way of saying
“You’re so wrong, I don’t even have to explain why you’re wrong.”
[6] What does any of this have to do with family court? Sadly, these days it has everything to
do with family court.
[7] Because when society demonizes and punishes anyone who disagrees – or even dares to
ask really important questions – the resulting polarization, disrespect, and simmering anger
can have devastating consequences for the mothers, fathers and children I deal with on a
daily basis.\
[8] It’s becoming harder for family court judges to turn enemies into friends -- when
governments are so recklessly turning friends into enemies.
[9] The motion before me is a typical – and frightening – example of how far we are drifting
from cherished values.
[10] The father wants two children ages 12 and 10 to receive COVID vaccinations. The mother
is opposed.
[11] Now, answer honestly. Did the previous paragraph give you enough information to form
an opinion about how this case should turn out?
[12] We’re all weary. We all wish COVID would just go away. But pandemic fatigue is no
excuse for short-cuts and lowering our standards. We all have to guard against the
unconscious bias of thinking “Why won’t these people just do what the government tells
them to do?”
[13] We have to decide on the basis of the best interests of each particular child in each
particular fact situation.
[14] We have to rely on – and insist upon – evidence.
[15] In this case the evidence provided more questions than answers.
a. The father filed two affidavits.
b. The mother filed one.
c. They both relied extensively on unsworn “exhibits”, which were basically
internet downloads.
d. In addition, the father relied on numerous downloads from the mother’s
social media accounts.
e. They both consented to my receiving these materials, to demonstrate the
sources of information which each of them is relying on in formulating their
respective parenting position.
...
[80] This is not the kind of case where the court can say that either side is necessarily correct.
Nor that the same determinations should apply for every child, no matter the circumstances.
[81] With the mother’s materials satisfying me that a legitimate and highly complex debate
exists on the efficacy and utilization of COVID vaccines, I am not prepared to apply
judicial notice as a method of resolving the issue. Anyone reading even some of the articles
presented by the mother would likely conclude that these are complicated and evolving
issues, and there can be no simplistic presumption that one side is right and that the other
side is comprised of a bunch of crackpots. That’s why the court should require evidence
rather than conclusory statements.
[82] The father insists the mother’s views have been debunked, but he provides no example of
any such determination actually having been made. It would be helpful if, once and for
all, the competing positions and science could be properly explored and tested in a public
trial.
[83] On balance, I am satisfied that that mother’s request for a cautious approach is compelling,
and reinforced by the children’s views and preferences which are legitimate and must be
respected. The mother has consistently made excellent decisions throughout the children’s
lives. Her current concerns about the vaccines are entirely understandable, given the
credible warnings and commentary provided by reputable sources who are specifically
acquainted with this issue.
[84] The mother has consistently made excellent, informed, and child-focussed decisions. In
every respect she is an exemplary parent, fully attuned to her children’s physical and
emotional needs. She has demonstrated a clear understanding of the science. She has
raised legitimate questions and concerns. I have confidence that she will continue to seek
out answers to safeguard the physical and emotional health of her children.
[85] She is not a bad parent – and no one is a bad citizen – simply by virtue of asking questions
of the government.
[86] At a certain point, where you have absolute confidence in a parent’s insight and decisionmaking, you have to
step back and acknowledge that they love their child; they have always
done the right thing for their child...and they will continue to do the right thing for their
child.
[87] The father’s motion is dismissed.
[88] The mother shall have sole decision-making authority with respect to the issue of
administering COVID vaccines for the children L.E.G. and M.D.G..
...
POSTSCRIPT:
[91] It’s irrelevant to my decision and it’s none of anyone’s business.
[92] But I am fully vaccinated. My choice.
[93] I mention this because I am acutely aware of how polarized the world has become.
[94] We should all return to discussing the issues rather than making presumptions about one
another
Pazaratz J.
Released: February 22, 2022
...
Full text (28 pages):
https://www.sirillp.com/wp-content/uploads/2022/03/Ontario-Family-Court-decision.pdf
sharon sanders
Editor-in-Chief & President
bump this
Emily
Editor, Senior Moderator
https://thehighwire.com/videos/are-we-doing-more-harm-than-good/
ARE WE DOING MORE HARM THAN GOOD?
Dr. Peter A. McCullough joins Del in studio for a dive into the science of vaccinating for Covid, vaccinating your children for Covid, and the risks and benefits. Is the risk worth the benefit? Are we doing more harm than good?
#DrPeterMcCullough #mRNASpikeProtein #EarlyCovidTreatment #Myocarditis
POSTED: March 10, 2022
ARE WE DOING MORE HARM THAN GOOD?
Dr. Peter A. McCullough joins Del in studio for a dive into the science of vaccinating for Covid, vaccinating your children for Covid, and the risks and benefits. Is the risk worth the benefit? Are we doing more harm than good?
#DrPeterMcCullough #mRNASpikeProtein #EarlyCovidTreatment #Myocarditis
POSTED: March 10, 2022
Pathfinder
Editor, Senior Moderator
The Pfizer documents
...
9 Mar 2022
Dr. John Campbell
2.27M subscribers
Public Health and Medical Professionals for Transparency, Pfizer / FDA FOI
https://phmpt.org
GardenSpider
Well-known member
The Express isn't exactly the New York Times, but I'll take it!
Pfizer vaccine: New documents uncover a shocking 158,000 adverse events.
PFIZER have included the common gastrointestinal symptoms, fatigue and brain fog as potential adverse events of the jab. According to new documents which have been released after a federal judge ordered the data to be made public.
https://www.express.co.uk/life-style/health/1577745/Pfizer-vaccine-side-effects-adverse-effects
Pfizer vaccine: New documents uncover a shocking 158,000 adverse events.
PFIZER have included the common gastrointestinal symptoms, fatigue and brain fog as potential adverse events of the jab. According to new documents which have been released after a federal judge ordered the data to be made public.
https://www.express.co.uk/life-style/health/1577745/Pfizer-vaccine-side-effects-adverse-effects
GardenSpider
Well-known member
Edward Dowd
COVID VACCINES KILLS 61,000 MILLENNIALS SINCE MID-2021
https://www.bitchute.com/video/dwxpxC30LaVO/
CDC data aggregated into age group for excess mortality ages 25-44
According to his data analyst, this age group experienced an 84% increase in excess mortality between summer and fall 2021.
See chart 4.
He contends that this is "the worst ever excess mortality in the history."
Summer and into fall were met with vaccinations and boosters.
More from Edward Dowd on the Corona Virus Investigative Committee.
EDWARD DOWD IS A FORMER PORTFOLIO MANAGER FOR BLACKROCK AND A WALL STEET EXPERT
https://www.bitchute.com/video/zj66gHoHO6k3/
COVID VACCINES KILLS 61,000 MILLENNIALS SINCE MID-2021
https://www.bitchute.com/video/dwxpxC30LaVO/
CDC data aggregated into age group for excess mortality ages 25-44
According to his data analyst, this age group experienced an 84% increase in excess mortality between summer and fall 2021.
See chart 4.
He contends that this is "the worst ever excess mortality in the history."
Summer and into fall were met with vaccinations and boosters.
More from Edward Dowd on the Corona Virus Investigative Committee.
EDWARD DOWD IS A FORMER PORTFOLIO MANAGER FOR BLACKROCK AND A WALL STEET EXPERT
https://www.bitchute.com/video/zj66gHoHO6k3/
GardenSpider
Well-known member
This is a follow up to an earlier post where an embalmer discovered mysterious fibrous white blood clots -- never before seen.
They began to show up in about 85% of the deceased, all of whom appeared to have received the CoVid-19 vaccination.
Samples of the long fibrous clots were sent to pathologist Ryan Cole for study. Here are his findings.
Pathologist on Ryan Cole on the mystery blood clots
https://rumble.com/vxeqvu-pathologist-on-ryan-cole-on-the-mystery-blood-clots.html
They began to show up in about 85% of the deceased, all of whom appeared to have received the CoVid-19 vaccination.
Samples of the long fibrous clots were sent to pathologist Ryan Cole for study. Here are his findings.
Pathologist on Ryan Cole on the mystery blood clots
https://rumble.com/vxeqvu-pathologist-on-ryan-cole-on-the-mystery-blood-clots.html
- Status